<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html id="nojs" xmlns="http://www.w3.org/1999/xhtml" xmlns:m="http://www.w3.org/1998/Math/MathML" xmlns:og="http://ogp.me/ns#" xml:lang="en-GB" lang="en-GB" xmlns:wb=“http://open.weibo.com/wb”>

<head>

   
  
      
  
                  
  
                  
  
            
  
            
            
    <title>Trials | Full text | Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial</title>
<link rel="shortcut icon" type="image/x-icon" href="/images/icon/10096/favicon.ico" />
<link rel="apple-touch-icon" sizes="72x72" href="/sites/10096/images/70.gif" />
<meta http-equiv="X-UA-Compatible" content="IE=7" />


                
    
		
		
		
		
<!-- <?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:cc="http://web.resource.org/cc/" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
<cc:Work rdf:about="http://www.trialsjournal.com/content/16/1/65">
<cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
</cc:Work>
<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
<cc:permits rdf:resource="http://web.resource.org/cc/Reproduction"/>
<cc:permits rdf:resource="http://web.resource.org/cc/Distribution"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Notice"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Attribution"/>
<cc:permits rdf:resource="http://web.resource.org/cc/DerivativeWorks"/>
</cc:License>
<item rdf:about="http://www.trialsjournal.com/content/16/1/65">
<title>Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial</title>
<dc:title>Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial</dc:title>
<dc:creator>El Hajj, Maguy S</dc:creator>
<dc:creator>Kheir, Nadir</dc:creator>
<dc:creator>Al Mulla, Ahmad M</dc:creator>
<dc:creator>Al-Badriyeh, Daoud</dc:creator>
<dc:creator>Al Kaddour, Ahmad</dc:creator>
<dc:creator>Mahfoud, Ziyad R</dc:creator>
<dc:creator>Salehi, Mohammad</dc:creator>
<dc:creator>Fanous, Nadia</dc:creator>
<dc:identifier>info:doi/10.1186/s13063-015-0570-z</dc:identifier>
<dc:source>Trials 2015, 16:65</dc:source>
<dc:date>2015-02-26</dc:date>

<prism:publicationName>Trials</prism:publicationName>
<prism:publicationDate>2015-02-26</prism:publicationDate>
<prism:volume>16</prism:volume>
<prism:number>1</prism:number>
<prism:section>Study protocol</prism:section>
<prism:startingPage>65</prism:startingPage>
<prism:copyright>2015 El Hajj et al.; licensee BioMed Central.</prism:copyright>
</item>
</rdf:RDF>
 -->
 
 
<meta name="citation_journal_title" content="Trials" />
<meta name="citation_publisher" content="BioMed Central Ltd" />


<meta name="citation_author" content="Maguy S El Hajj" />
<meta name="citation_author_institution" content="College of Pharmacy, Qatar University, Doha, Qatar" />
<meta name="citation_author" content="Nadir Kheir" />
<meta name="citation_author_institution" content="College of Pharmacy, Qatar University, Doha, Qatar" />
<meta name="citation_author" content="Ahmad M Al Mulla" />
<meta name="citation_author_institution" content="Smoking Cessation Clinic, Medicine Department, Hamad Medical Corporation, Doha, Qatar" />
<meta name="citation_author" content="Daoud Al-Badriyeh" />
<meta name="citation_author_institution" content="College of Pharmacy, Qatar University, Doha, Qatar" />
<meta name="citation_author" content="Ahmad Al Kaddour" />
<meta name="citation_author_institution" content="College of Pharmacy, Qatar University, Doha, Qatar" />
<meta name="citation_author" content="Ziyad R Mahfoud" />
<meta name="citation_author_institution" content="Department of Health Care Policy and Research, Weill Cornell Medical College, New York, NY, USA" />
<meta name="citation_author_institution" content="Department of Global and Public Health, Weill Cornell Medical College, Doha, Qatar" />
<meta name="citation_author" content="Mohammad Salehi" />
<meta name="citation_author_institution" content="Department of Mathematics, Statistics and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar" />
<meta name="citation_author" content="Nadia Fanous" />
<meta name="citation_author_institution" content="Smoking Cessation Clinic, Medicine Department, Hamad Medical Corporation, Doha, Qatar" />


<meta name="citation_issn" content="1745-6215" />
<meta name="citation_title" content="Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial" />
<meta name="citation_volume" content="16" />
<meta name="citation_issue" content="1" />
<meta name="citation_date" content="2015-02-26" />
<meta name="citation_firstpage" content="65" />
<meta name="citation_doi" content="10.1186/s13063-015-0570-z" />
<meta name="citation_pdf_url" content="http://www.trialsjournal.com/content/pdf/s13063-015-0570-z.pdf" />
<link rel="alternate" type="application/pdf" title="PDF" href="http://www.trialsjournal.com/content/pdf/s13063-015-0570-z.pdf" />
<meta name="title" content="Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial" />
<meta name="description" content="It had been reported that up to 37% of the adult male population smokes cigarettes in Qatar. The Global Youth Tobacco Survey also stated that 13.4% of male school students aged 13 to 15 years in Qatar smoke cigarettes. Smoking cessation is key to reducing smoking-related diseases and deaths. Healthcare providers are in an ideal position to encourage smoking cessation. Pharmacists are the most accessible healthcare providers and are uniquely situated to initiate behavior change among patients. Many studies have shown that pharmacists can be successful in helping patients quit smoking. Studies demonstrating the effectiveness of pharmacist-delivered smoking cessation programs are lacking in Qatar. This proposal aims to test the effect of a structured smoking cessation program delivered by trained ambulatory pharmacists in Qatar." />

<meta name="dc.title" content="Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial" />
<meta name="dc.creator" content="El Hajj, Maguy S" />
<meta name="dc.creator" content="Kheir, Nadir" />
<meta name="dc.creator" content="Al Mulla, Ahmad M" />
<meta name="dc.creator" content="Al-Badriyeh, Daoud" />
<meta name="dc.creator" content="Al Kaddour, Ahmad" />
<meta name="dc.creator" content="Mahfoud, Ziyad R" />
<meta name="dc.creator" content="Salehi, Mohammad" />
<meta name="dc.creator" content="Fanous, Nadia" />
<meta name="dc.description" content="It had been reported that up to 37% of the adult male population smokes cigarettes in Qatar. The Global Youth Tobacco Survey also stated that 13.4% of male school students aged 13 to 15 years in Qatar smoke cigarettes. Smoking cessation is key to reducing smoking-related diseases and deaths. Healthcare providers are in an ideal position to encourage smoking cessation. Pharmacists are the most accessible healthcare providers and are uniquely situated to initiate behavior change among patients. Many studies have shown that pharmacists can be successful in helping patients quit smoking. Studies demonstrating the effectiveness of pharmacist-delivered smoking cessation programs are lacking in Qatar. This proposal aims to test the effect of a structured smoking cessation program delivered by trained ambulatory pharmacists in Qatar." />
<meta name="dc.source" content="Trials 2015 16:65" />
<meta name="dc.format" content="text/html" />
<meta name="dc.publisher" content="BioMed Central Ltd" />
<meta name="dc.date" content="2015-02-26" />
<meta name="dc.type" content="Study protocol" />
<meta name="dc.identifier" content="10.1186/s13063-015-0570-z" />
<meta name="dc.language" content="en" />
<meta name="dc.copyright" content="2015 El Hajj et al.; licensee BioMed Central." />
<meta name="dc.rights" content="http://creativecommons.org/licenses/by/2.0/" />
<meta name="dc.rightsAgent" content="reprints@biomedcentral.com" />

<meta name="prism.issn" content="1745-6215" />
<meta name="prism.publicationName" content="Trials" />
<meta name="prism.publicationDate" content="2015-02-26" />
<meta name="prism.volume" content="16" />
<meta name="prism.number" content="1" />
<meta name="prism.section" content="Study protocol" />
<meta name="prism.startingPage" content="65" />
<meta name="prism.copyright" content="2015 El Hajj et al.; licensee BioMed Central." />
<meta name="prism.rightsAgent" content="reprints@biomedcentral.com" />


        <meta name="citation_abstract_html_url" content="http://www.trialsjournal.com/content/16/1/65/abstract" />
            <meta name="citation_fulltext_html_url" content="http://www.trialsjournal.com/content/16/1/65" />
            <link rel='alternate' type='text/xml' title='XML version' href='http://www.trialsjournal.com/content/download/xml/s13063-015-0570-z.xml' />
            <link rel="image_src" href="http://www.trialsjournal.com/content/figures/s13063-015-0570-z-toc.gif" />
    
    
    
    
                    
    

<script type="text/javascript">
// must run before css
document.documentElement.id = "js";
</script>



						
   
  
      
  
                  
  
                  
  
            
  
            
            



						
        <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery-1.8.2.min-0.js"></script>

	                <link rel="stylesheet" type="text/css" href="/css/main-0.css" media="screen, print"/>
    
                <link rel="stylesheet" type="text/css" href="/css/plugins-0.css" media="screen, print"/>
    



    

			                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/articles-0.css" media="screen, print"/>
    	

    

    <link rel="stylesheet" type="text/css" href="/css/themes/10096.css" media="screen, print"/>


                <link rel="stylesheet" type="text/css" href="/css/media/print-0.css" media="print"/>
    



<!--[if IE]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie-0.css"/>
    <![endif]-->

<!--[if IE 7]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie7-0.css"/>
    <![endif]-->
			
<script type="text/javascript">
    //configuration
    OAS_url = '//oas.biomedcentral.com/RealMedia/ads/';

	// control of advert's position on page [AMC]
    
    	
	
    OAS_sitepage = "trialsjournal.com/article/10.1186/s13063/015/0570/z";
    	
		OAS_listpos = 'Top,x96,Right3';
	
	
			
		OAS_query = '';
		
	

    OAS_target = '_top';
    //end of configuration
    OAS_version = 10;
    OAS_rn = '001234567890'; OAS_rns = '1234567890';
    OAS_rn = new String (Math.random()); OAS_rns = OAS_rn.substring (2, 11);
    function OAS_NORMAL(pos) {
		document.write('<a href="' + OAS_url + 'click_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" target="' + OAS_target + '">');
		document.write('<img src="' + OAS_url + 'adstream_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" border="0"/></a>');
    }
    
	function refererTerms(referer) {

	if(referer.match("q=") != null) {
		referer = referer.split("q=");
		referer = referer[1].split("&");
		referer = referer[0];
	} else {
		referer = referer;
	}

		if(referer.match("%20") != null && referer.match("%20").length >= 1) {
			referer =  referer.replace(/%20/gi,"+");
			return referer;
		} else { 
			return referer; 
		}
	}
 </script>


 <script type="text/javascript">
	// Set the version of JavaScript to 10 for a Browser 'Mozilla/3' on webTV 
    OAS_version = 11;
    if ((navigator.userAgent.indexOf('Mozilla/3') != -1) || (navigator.userAgent.indexOf('Mozilla/4.0 WebTV') != -1)) {
     OAS_version = 10; }
    if (OAS_version >= 11) {
    document.write('<scr' + 'ipt type="text/javascript" src="' + OAS_url + 'adstream_mjx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '?' + OAS_query + '"><\/script>'); }
</script>
	
<script type="text/javascript">
    document.write('');
	
    function OAS_AD(pos) {
        if (OAS_version >= 11)
         OAS_RICH(pos);
        else
         OAS_NORMAL(pos);
    }
 </script>
	





<script type="text/javascript">
    jsonLoaders = function(){
        var _loaders = [];
        return {
            register: function(config){
                config.prefix = config.prefix || '/webapi/1.0/blogs/';
                config.feedLength = config.feedLength || 3;

                _loaders.push(config);
            },
            list: function(){return _loaders}
        };
    }();

    function totext() {
	    document.write('<a href="javascript:returnToText();">Return to text</a>');
    }

    function retrieve_doi(){
        var metas = document.getElementsByTagName('meta');
        var i;
        for (i = 0; i < metas.length; i++)
            if (metas[i].getAttribute('name') == "citation_doi")
                break;
        var citation_doi = metas[i].getAttribute('content');
        return citation_doi;
    }

</script>





    <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script>
        <link title="Latest articles" rel="alternate" href="http://www.trialsjournal.com/latest/rss" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Most viewed" rel="alternate" href="http://www.trialsjournal.com/mostviewed/rss/" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Latest comments" rel="alternate" href="http://www.trialsjournal.com/latestcomments/rss" type="application/rss+xml" exposeToHeader="true"/>
    


	<script type="text/javascript">
	var _gaq = _gaq || [];
	_gaq.push(['_setAccount', 'UA-9663741-5']);
	_gaq.push(['_gat._anonymizeIp']);
	_gaq.push(['_setLocalRemoteServerMode']);
	
	/*for cross domain tracking*/
	//_gaq.push(['_setAllowLinker', true]);
    //_gaq.push(['_setDomainName', 'trialsjournal.com']); //this journal's domain
	/**/
	
		_gaq.push(['_trackPageview']); 

	(function() {
		var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
		ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
		var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);

		//var iframe = document.getElementById('casesdb-search-widget');
		//if(iframe !== null) {
		//	var pageTracker = _gat._getTrackerByName();
		//	iframe.src = pageTracker._getLinkerUrl('http://www.casesdatabase.com/');
		//}
	})();
	</script>

	
        </head>


<body class=" theme    ">


        



   
  
      
  
                  
  
                  
  
            
  
            
            

    

<div id="oas-campaign" style="display:none">trialsjournal.com/article/10.1186/s13063/015/0570/z</div>
<div id="oas-positions" style="display:none">Bottom,Top</div>

<div id="branding" role="banner">
                			
		<dl class="google-ad wide ">
	<dt class="hide">
					<a class="banner-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising"></a>
				
			</dt>
		<dd>

		<!-- OAS AD 'Top' begin -->
		<script type="text/javascript">
		OAS_AD('Top');

		</script>
		<!-- OAS AD 'Top' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad wide noscript">  
    <dt class="hide"></dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0570/z/18811611408@Top?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0570/z/13433583997@Top?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
			            <div class="sup-panel-outer">
        <div class="sup-panel-inner">

            <style>
  #nojs li.greeting, #nojs li#loginLink {display:none;}
</style>


<ul id="login" class="login">

    <noscript><li><a href="/log"><img class="greeting" src="/images/log.gif"/></a></li></noscript>
    
    <li id="welcome"><span id="username"></span></li>

    <li id="loginLink"><a href=""></a></li>
    
    
</ul>

<script>

function login() {

/* cookie getter/setter */
var allCookies = {
  getItem: function (sKey) {
    if (!sKey || !this.hasItem(sKey)) { return null; }
    return unescape(document.cookie.replace(new RegExp("(?:^|.*;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=\\s*((?:[^;](?!;))*[^;]?).*"), "$1"));
  },
  setItem: function (sKey, sValue, vEnd, sPath, sDomain, bSecure) {
    if (!sKey || /^(?:expires|max\-age|path|domain|secure)$/i.test(sKey)) { return; }
    var sExpires = "";
    if (vEnd) {
      switch (vEnd.constructor) {
        case Number:
          sExpires = vEnd === Infinity ? "; expires=Tue, 19 Jan 2038 03:14:07 GMT" : "; max-age=" + vEnd;
          break;
        case String:
          sExpires = "; expires=" + vEnd;
          break;
        case Date:
          sExpires = "; expires=" + vEnd.toGMTString();
          break;
      }
    }
    document.cookie = escape(sKey) + "=" + escape(sValue) + sExpires + (sDomain ? "; domain=" + sDomain : "") + (sPath ? "; path=" + sPath : "") + (bSecure ? "; secure" : "");
  },
  removeItem: function (sKey, sPath) {
    if (!sKey || !this.hasItem(sKey)) { return; }
    document.cookie = escape(sKey) + "=; expires=Thu, 01 Jan 1970 00:00:00 GMT" + (sPath ? "; path=" + sPath : "");
  },
  hasItem: function (sKey) {
    return (new RegExp("(?:^|;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=")).test(document.cookie);
  },
  keys: /* optional method: you can safely remove it! */ function () {
    var aKeys = document.cookie.replace(/((?:^|\s*;)[^\=]+)(?=;|$)|^\s*|\s*(?:\=[^;]*)?(?:\1|$)/g, "").split(/\s*(?:\=[^;]*)?;\s*/);
    for (var nIdx = 0; nIdx < aKeys.length; nIdx++) { aKeys[nIdx] = unescape(aKeys[nIdx]); }
    return aKeys;
  }
};

// converts cookie into js object
function parseCookie(cookie) {

    cookie = cookie.split("&");
    var obj = {};

    for(var i = 0; i < cookie.length; i++) {

        var c = cookie[i].split("=");

        c[0] = c[0].replace('"','');
        
        obj[c[0]] = c[1];

    }
    return obj;
}

    var cookie = allCookies.getItem("bmccookie");

    var obj = (cookie != null) ? parseCookie(cookie) : {};
    

        var welcome = "";

        if(obj.hasOwnProperty("fname")) {

            // insert user welcome
            welcome = obj.fname.replace(/\+/g, " ") + " " + obj['lname'].replace(/\+/g," ");

            if(jQuery("#welcome").length > 0) {
              jQuery("#welcome").prepend("<strong>Welcome</strong> ");
              jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log off");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logoff");

            window.bmcloggedon = true;


        } else if(obj.hasOwnProperty("institution_name")) {

            // insert institution name
            welcome = obj["institution_name"].replace(/\+/g," ");
            
            if(jQuery("#welcome").length > 0) { 
                jQuery("#welcome").prepend("<strong>Welcome</strong> ");
                jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;


        } else {
            jQuery("#welcome").innerHTML = "";
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;

        }


        // if athens login cookie doesn't exist and the athens login link is visible then remove it.
        if(allCookies.hasItem("athens") != true && document.getElementById("loginAthensLink") != null) {
          jQuery("#loginAthensLink").hide();
        }

}

login();


</script>

            <ul class="nav-sup">

    
        <li id="BMC" class="current">
            <a href="http://www.biomedcentral.com/"><span class="img-title">&nbsp;</span>
            <span class="text-title">BioMed Central</span></a>
        </li>
		
        		<li><a href="http://www.biomedcentral.com/journals"><span>Journals</span></a></li>
		
								<li>
				<a href="http://www.biomedcentral.com/gateways"><span>Gateways</span></a>
			</li>
					    	
</ul>
        </div>
    </div>
    <div class="branding-inner">

        

    
<style>
.survey {
	margin: 10px 0;
}
.survey, .survey .survey-sentence {
	font-size: 13px;
}
.survey-button a, .survey-button a:active, .survey-button a:visited, .survey-button a:hover  {
    color: #FFFFFF;
    text-decoration: none;
}
.survey-button {
	background-color: #FFA500;
    border-radius: 5px;
    color: #FFFFFF;
    font-weight: bold;
    font-size: 13px;
    font-weight: bold;
    padding: 5px 13px;
    background: #ef8142; /* Old browsers */
	background: -moz-linear-gradient(top,  #ef8142 0%, #ef8142 50%, #a64510 100%, #a64510 100%); /* FF3.6+ */
	background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,#ef8142), color-stop(50%,#ef8142), color-stop(100%,#a64510), color-stop(100%,#a64510)); /* Chrome,Safari4+ */
	background: -webkit-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Chrome10+,Safari5.1+ */
	background: -o-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Opera 11.10+ */
	background: -ms-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* IE10+ */
	background: linear-gradient(to bottom,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* W3C */
	filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#ef8142', endColorstr='#a64510',GradientType=0 ); /* IE6-9 */

}
</style>




          <div class="logo">
        <a href="/"><img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" /></a>     
      </div>    
        
                    



            <div id="impact-factor" class="official">
    <img src="/images/branding/official.gif" alt="official impact factor" title="2.12"/>
    <span id="impact-factor-value">2.12</span>
</div>
    
                            

<div class="module search gray small  " role="search">
    <div class="module-inner padded">
        <form method="get" class="searchForm"
              action=" /quickSearchRedirectURL "
              onsubmit="window.location.href=this['url'].value + '?terms=' + encodeURIComponent(this['terms'].value); return false;">
            <fieldset class="search">
			                <span>
                    Search <select name="url">
                                <option value="http://www.trialsjournal.com/search/results" selected>Trials</option>
                                <option value="http://www.biomedcentral.com/search/results">BioMed Central</option>
                           </select> for
                </span>
                            <input id="searchTerms" name="terms" type="text" alt="Search terms" class="text " />
                 <button class="w37" value="Go" type="submit">Go</button>
            </fieldset>
        </form>
    </div>
	<a class="advanced-search" href="/search">Advanced search</a>
</div> 

                        <div id="mobile-nav-list" >

	<ul class="primary-nav" role="navigation">
		<li     ><a href="/"><span id="home-tab">Home</span></a></li>
														<li             class="current"
    ><a href="/content"><span id="articles-tab">Articles</span></a></li>
										
	

	
            <li     ><a href="/authors/instructions"><span id="authors-tab">Authors</span></a></li>
        <li     ><a href="/about/reviewers"><span id="reviewers-tab">Reviewers</span></a></li>
    		<li     ><a href="/about"><span id='about-tab'>About this journal</span></a></li>
	<li     ><a href="/my"><span id="my-tab">My Trials</span></a></li>
		
    		</ul>
</div>
            </div>
</div>

<hr class="hide" />
<div class="container">
	<div id="content"  class="overflow-visible"  role="main">
			    
	

<!--div class="branding-mobile">
		<h1 class="logo">
	    <a href="/">
		    <img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" />
		</a>
		</h1>
	</div><br/-->



			
	



<div class="outline-wrapper block mobile-hidden" id="left-article-box">
<ul id="box-outline" class="box">
<ul id="outline" class="outline">
   <li>
      <a href="#">Top</a>
   </li>
   <li>
      <a href="#abs">Abstract</a>
   </li>
   <li>
      <a href="#sec1">Background</a>
   </li>
   <li>
      <a href="#sec2">Methods/design</a>
   </li>
   <li>
      <a href="#sec3">Discussion</a>
   </li>
   <li>
      <a href="#sec4">Trial status</a>
   </li>
   <li>
      <a href="#sec5">Abbreviations</a>
   </li>
   <li>
      <a href="#sec6">Competing interests</a>
   </li>
   <li>
      <a href="#sec7">Authors’ contributions</a>
   </li>
   <li>
      <a href="#ack">Acknowledgments</a>
   </li>
   <li class="lowest">
      <a href="#refs">References</a>
   </li>
</ul>
</ul>

<dl id="box-outline1">
</dl>

				



</div>



<div class="mobile-hidden" id="right-panel">
 	
<div id="mobile-sidebar">
	<div id="mobile-sidebar-tab">
		<span>
			<a href="#" id="mobile-sidebar-tab-link"><img src="/images/sidebar-hidden.png"><img style="display:none;" src="/images/sidebar-shown.png"></a>
		</span>
	</div>	<div id="mobile-sidebar-list">

<div id="article-navigation-bar">
    <div class="issue-information block">
        <h5><a href="http://www.trialsjournal.com"><strong>Trials</strong></a></h5>
 		        <ul class="square normal">
            <li><a href="http://www.trialsjournal.com/content/16">Volume 16</a></li>
				
                    </ul>
    </div>

    <div class="article-information block" id="article-info">
        


<div id="viewing-options-links">
	<h5>Viewing options</h5>
	<ul class="square normal">
        
            <li>
                             <a onclick="_gaq.push(['_trackEvent', 'Abstract', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/16/1/65/abstract">Abstract</a>
                        </li>
        				<li>
							<strong>Full text</strong>
					</li>
				
		<li class="pdfFileSize">
			<a onclick="_gaq.push(['_trackEvent', 'PDF download', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/pdf/s13063-015-0570-z.pdf">PDF</a>
			<span>(526KB)</span>
		</li>

        
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'additional files', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/16/1/65/additional">Additional files</a>
					</li>
			</ul>

        
</div>
		
<div id="associated-material-links">
    <h5>Associated material</h5>
    <ul class="square normal">
                                    <li><a onclick="_gaq.push(['_trackEvent', 'Article metrics', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/16/1/65/about">Article metrics</a></li>
                <li>
                        <a onclick="_gaq.push(['_trackEvent', 'Readers comments', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/16/1/65/comments">Readers' comments </a>
                    </li>
        <li>
                            <a onclick="_gaq.push(['_trackEvent', 'Pre-publication history', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/16/1/65/prepub">Pre-publication history</a>                    </li>
    </ul>
</div>
		




<div id="related-literature-links">
    <h5>Related literature</h5>
    <ul class="normal">
                    <li><a onclick="_gaq.push(['_trackEvent', 'Citied by', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://www.trialsjournal.com/content/16/1/65/about#citations">Cited by</a></li>
                <li id="google-blog-search"><a onclick="_gaq.push(['_trackEvent', 'Google blog search', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://www.google.com/search?tbm=blg&hl=en&amp;source=hp&amp;biw=1280&amp;bih=899&amp;q=%22Assessing+the+effectiveness+of+a+pharmacist-delivered+smoking+cessation+program+in+the+State+of+Qatar%3A+study+protocol+for+a+randomized+controlled+trial%22&amp;btnG=Search">Google blog search</a></li>
        <h6>Other articles by authors</h6>
        <li>
            <a class="collapser"><i>&nbsp;</i>on Google Scholar</a>
<ul id="authg" class="hidebeforeload">                         <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22MS+El Hajj%22">El Hajj MS</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22N+Kheir%22">Kheir N</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22AM+Al Mulla%22">Al Mulla AM</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22D+Al-Badriyeh%22">Al-Badriyeh D</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22A+Al Kaddour%22">Al Kaddour A</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22ZR+Mahfoud%22">Mahfoud ZR</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22M+Salehi%22">Salehi M</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22N+Fanous%22">Fanous N</a>
            </li>
            </ul>          </li>
                <li>
            	        </li>
    </ul>     <h6>Related articles/pages</h6>
    <ul class="square normal">
        <li><a onclick="_gaq.push(['_trackEvent', 'on google', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://www.google.co.uk/search?hl=en&amp;q=related:http://www.trialsjournal.com/content/16/1/65">on Google</a></li>
        <li><a onclick="_gaq.push(['_trackEvent', 'on google scholar', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://scholar.google.com/scholar?q=related:http://www.trialsjournal.com/content/16/1/65">on Google Scholar</a></li>
            </ul>

</div>		
        
    
    
        

    	






<h5>Tools</h5>
	<ul class="square normal">
									<li>
						<a onclick="_gaq.push(['_trackEvent', 'download references', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/16/1/65/citation">Download references</a>
					</li>
				<li><a onclick="_gaq.push(['_trackEvent', 'download xml', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/download/xml/s13063-015-0570-z.xml">Download XML</a></li>
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'email2friend', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/16/1/65/email">Email to a friend</a>
					</li>
		<li><a onclick="_gaq.push(['_trackEvent', 'order reprints', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=738&doi=10.1186/s13063-015-0570-z&volume=16&issue=1&title=Assessing+the+effectiveness+of+a+pharmacist-delivered+smoking+cessation+program+in+the+State+of+Qatar%3A+study+protocol+for+a+randomized+controlled+trial&author_name=Maguy Saffouh El Hajj&start_page=1&end_page=12">Order reprints</a></li>
		<li>
						<a onclick="_gaq.push(['_trackEvent', 'post a comment', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/16/1/65/postcomment">Post a comment</a>
					</li>			
		<ul id="download-to-links">
			<a class="downloadto_title btn" href="#"><span class="icon">&nbsp;</span>Download to ...</a>
			
			<ul id="downloadto" class="iconlist hidebeforeload" style="display: none;">
				<li>
					<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F65" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/65', 1, true]);"><span class="share-icons papers"></span>Papers</a>
				</li>
				<li>
					<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/65" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/65', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
				</li>
			</ul>
		</ul>
		
		<ul id="mobile-downloadto" class="iconlist">
		
		<h6>Download to ...</h6>
			<li>
				<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F65" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/65', 1, true]);"><span class="share-icons papers"></span>Papers</a>
			</li>
			
			<li>
				<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/65" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/65', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
		</ul>

		
	</ul>
		




<h5>Share this article</h5>
<ul id="social-networking-links">
	<li>
	<div class="fb-like" onclick="_gaq.push(['_trackEvent', 'Facebook Recommend', 'Article Sidebar', '/content/16/1/65', 1, true]);" data-href="http://www.trialsjournal.com/content/16/1/65" data-send="false" data-layout="button_count" data-width="100" data-show-faces="false" data-action="recommend"></div>
	</li>
	<li>
		<a onclick="_gaq.push(['_trackEvent', 'Share Twitter Recommend', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://twitter.com/share" data-url="http://www.trialsjournal.com/content/16/1/65" data-counturl="http://www.trialsjournal.com/content/16/1/65" data-hashtags="trials
" data-text="Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial" class="twitter-share-button">Tweet</a>
	</li>
	<li>
			<g:plusone size="medium" width="100"></g:plusone>
	</li>

        <li>
        <wb:share-button onclick="_gaq.push(['_trackEvent', 'Recommend Google plus', 'Article Sidebar', '/content/16/1/65', 1, true]);" addition="number" type="button" ralateUid="2216240737" title="Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial http://www.trialsjournal.com/content/16/1/65"></wb:share-button>
    </li>
    
		<a class="sharethis_title btn" href="#"><span class="icon">&nbsp;</span>More options...</a>
	<ul class="iconlist hidebeforeload" id="sharethis">
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'citeu Like', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://www.citeulike.org/posturl?url=http://www.trialsjournal.com/content/16/1/65"><span class="share-icons citeulike"></span>Citeulike</a>
			</li>
				<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Linkedin', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://www.linkedin.com/shareArticle?mini=true&url=%26%2335%3Btrials%0D%0AAssessing%20the%20effectiveness%20of%20a%20pharmacist-delivered%20smoking%20cessation%20program%20in%20the%20State%20of%20Qatar%3A%20study%20protocol%20for%20a%20randomized%20controlled%20trial%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F65&title=Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial"><span class="share-icons linkedin"></span>LinkedIn</a>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share delicious', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://del.icio.us/post?url=http://www.trialsjournal.com/content/16/1/65&title=Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial"><span class="share-icons delicious"></span>Del.icio.us</a>
	</li>
			<li>
				<a onclick="_gaq.push(['_trackEvent', 'Share via email', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="/content/16/1/65/email"><span class="share-icons email"></span>Email</a>
	</li>
			<li>
				<a onclick="target="_blank" onclick="_gaq.push(['_trackEvent', 'Share facebook', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://www.facebook.com/sharer.php?u=http://www.trialsjournal.com/content/16/1/65"><span class="share-icons facebook"></span>Facebook</a>
	</li>
	<li class="gp">
			<div class="googlehider mobile-hide"> 
				<div class="g-plusone" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus mobile-hide"></span>
				<div class="googlehider2 mobile-hide"> 
				<div class="g-plusone mobile-hide" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus"></span>
				<span class="gp-link"><a  onclick="_gaq.push(['_trackEvent', 'Share google plus', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="#">Google+</a></span>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Mandeley', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/65"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
			<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share twitter icon', 'Article Sidebar', '/content/16/1/65', 1, true]);" href="http://twitter.com/?status=Assessing%20the%20effectiveness%20of%20a%20pharmacist-delivered%20smoking%20cessation%20program%20in%20the%20State%20of%20Qatar%3A%20study%20protocol%20for%20a%20randomized%20controlled%20trial%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F65+%23trials
"><span class="share-icons twitter"></span>Twitter</a>
			</li>

			<li><a href="http://www.reddit.com/submit" onclick="window.location = 'http://www.reddit.com/submit?url=http://www.trialsjournal.com/content/16/1/65'; return false"> <span class="share-icons reddit"></span>Reddit</a>
    </li>






		</ul>
</ul>

    </div>

    
  
        
                
        


















                                                                                
	

	    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="signup-to-etoc" class="button-collection-margins block mobile-border-bottom">	
					<h3>Email updates</h3>
			<p id="receive_issue_alerts_journal_updates_text">Keep up to date with the latest news and content from Trials and BioMed Central.</p>
			
				
<form  id="articleSignupForUpdates"  method="post" action="/signuptoupdates.html">
	<div id="message-box"></div>
    <fieldset class="block-form">
        <input type="text" name="emailAddress" onblur="javascript: if (this.value == '') { this.value = 'email address'; }" onfocus="javascript: if (this.value == 'email address') { this.value = ''; }" value="email address"  class="text " id="email" />
        <input value="" type="hidden" name="returnUrl" id="returnUrl" />
        <input value="xniche-trials" type="hidden" name="listName" id="listName" />
        <input value="Trials" type="hidden" name="journalName" id="journalName" />
        <button onclick="_gaq.push('_trackEvent', 'Signup', 'Signup for Email updates', "Trials");" class="w74 right" type="submit" onmouseover="this.className='w74 hover right'" onmouseout="this.className='w74 right'" value="Sign up">Sign up</button>
    </fieldset>
</form>	
</div>

	


			<div id="advert-offset">
    					
		<dl class="google-ad  ">
	<dt class="hide">
				
					<a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
			</dt>
		<dd>

		<!-- OAS AD 'Right3' begin -->
		<script type="text/javascript">
		OAS_AD('Right3');

		</script>
		<!-- OAS AD 'Right3' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad  noscript">  
    <dt class="hide"><a href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0570/z/15615002578@Right3?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0570/z/16194758507@Right3?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
					</div>
	

	
</div>
		<div class="mobile-sidebar-gradient top"></div>
		<div class="mobile-sidebar-gradient bottom"></div>
	</div>

</div>








 </div>
<div class="rounded custom white article full-text">
<div class="wrap-inner content">
    <div class="padded-inner">            


    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="topmatter">
	


	   






 
  



				<a href="/about/access"><img alt="Open Access" src="/images/articles/openaccess-large.png" class="access mr15"/></a>
					<span class="articletype">Study protocol</span>

<h1>Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial</h1>
        
			<div class="multipleins">
		
	<p class="authors">
        																																																																																																																																																																																																																																																																			         <strong>Maguy Saffouh El Hajj</strong><sup><a href="/content/16/1/65/#ins1">1</a></sup><sup>&#42;</sup>, <strong>Nadir Kheir</strong><sup><a href="/content/16/1/65/#ins1">1</a></sup>, <strong>Ahmad Mohd Al Mulla</strong><sup><a href="/content/16/1/65/#ins2">2</a></sup>, <strong>Daoud Al-Badriyeh</strong><sup><a href="/content/16/1/65/#ins1">1</a></sup>, <strong>Ahmad Al Kaddour</strong><sup><a href="/content/16/1/65/#ins1">1</a></sup>, <strong>Ziyad R Mahfoud</strong><sup><a href="/content/16/1/65/#ins3">3</a></sup><sup><a href="/content/16/1/65/#ins4">4</a></sup>, <strong>Mohammad Salehi</strong><sup><a href="/content/16/1/65/#ins5">5</a></sup> and <strong>Nadia Fanous</strong><sup><a href="/content/16/1/65/#ins2">2</a></sup>	</p>
	
				<div id="affiliations">
		<div class="module gray  inner">
<div class="module-inner padded-inner">
		<ul>
			<li>                        
                                                                                                                		<p class="authors" >
							<span>*</span>
									 Corresponding author:										            Maguy S El Hajj <a href='mailto:maguyh@qu.edu.qa'>maguyh@qu.edu.qa</a>    					</p>
      
</li>
			
                                                                                                                                                                                                                                                		</ul>

		
		 <p class="options"><a class="affiliations-toggle" href="#"><i class="arrow"></i>Author Affiliations</a></p>            <section> 
						<div class="collapsible-content">
							
				<div id="ins_container" style="display: block;">
										    						    <p >
						        <sup id="ins1">1</sup>                                College of Pharmacy, Qatar University, Doha, Qatar
                            </p>
																    						    <p >
						        <sup id="ins2">2</sup>                                Smoking Cessation Clinic, Medicine Department, Hamad Medical Corporation, Doha, Qatar
                            </p>
																    						    <p >
						        <sup id="ins3">3</sup>                                Department of Health Care Policy and Research, Weill Cornell Medical College, New York, NY, USA
                            </p>
																    						    <p >
						        <sup id="ins4">4</sup>                                Department of Global and Public Health, Weill Cornell Medical College, Doha, Qatar
                            </p>
																    						    <p >
						        <sup id="ins5">5</sup>                                Department of Mathematics, Statistics and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar
                            </p>
																
				</div>
										<p id="authoremails">            For all author emails, please <a href="/logon">log on</a>.
    </p>
						</div>
			</section>
				</div>
</div>
		</div>
	  </div>

            <section class="cit">
                        <div class="collapsible-content">
        <p><em>Trials</em> 2015, <strong>16</strong>:65&nbsp;
			<span class="pseudotab">doi:10.1186/s13063-015-0570-z</span></p>
	    				    
    
        
                
		<p>The electronic version of this article is the complete one and can be found online at: <a href="http://www.trialsjournal.com/content/16/1/65">http://www.trialsjournal.com/content/16/1/65</a></p>
		<br/>
                    <table cellspacing="0" cellpadding="0">
        <tbody>
        <tr><td>Received:</td><td>14 June 2014</td></tr>                <tr><td>Accepted:</td><td>19 January 2015</td></tr>        <tr><td>Published:</td><td>26 February 2015</td></tr>        </tbody>
        </table>
    		<!--<br/>-->
		<div  style="line-height:140%">
        <p>
            &copy; 2015 El Hajj et al.; licensee BioMed Central. <br />
        </p>
					<p>
				This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href='http://creativecommons.org/licenses/by/4.0'>http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
			</p>
		    	</div>
	</section>

</div>
<div id="article-body">
    <section><a name="abs"></a><h3>Abstract</h3>
   <div class="collapsible-content">
      <h4>Background</h4>
      <p style="line-height:160%">It had been reported that up to 37% of the adult male population smokes cigarettes
         in Qatar. The Global Youth Tobacco Survey also stated that 13.4% of male school students
         aged 13 to 15 years in Qatar smoke cigarettes. Smoking cessation is key to reducing
         smoking-related diseases and deaths. Healthcare providers are in an ideal position
         to encourage smoking cessation. Pharmacists are the most accessible healthcare providers
         and are uniquely situated to initiate behavior change among patients. Many studies
         have shown that pharmacists can be successful in helping patients quit smoking. Studies
         demonstrating the effectiveness of pharmacist-delivered smoking cessation programs
         are lacking in Qatar. This proposal aims to test the effect of a structured smoking
         cessation program delivered by trained ambulatory pharmacists in Qatar.
      </p>
      <h4>Methods/Design</h4>
      <p style="line-height:160%">A prospective, randomized, controlled trial is conducted at eight ambulatory pharmacies
         in Qatar. Participants are randomly assigned to receive an at least four-session face-to-face
         structured patient-specific smoking cessation program conducted by the pharmacist
         or 5 to 10 min of unstructured brief smoking cessation advice (emulating current practice)
         given by the pharmacist. Both groups are offered nicotine replacement therapy if feasible.
         The primary outcome of smoking cessation will be confirmed by an exhaled carbon monoxide
         test at 12 months. Secondary outcomes constitute quality-of-life adjustment as well
         as cost analysis of program resources consumed, including per case and patient outcome.
      </p>
      <h4>Discussion</h4>
      <p style="line-height:160%">If proven to be effective, this smoking cessation program will be considered as a
         model that Qatar and the region can apply to decrease the smoking burden.
      </p>
      <h4>Trial registration</h4>
      <p style="line-height:160%">Clinical Trials <a href="NCT02123329">NCT02123329</a> <a href="http://www.webcitation.org/query.php?url=NCT02123329&amp;refdoi=10.1186/s13063-015-0570-z" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a>.
      </p>
   </div>
</section><span id="keywords">
   <h5 class="inline">Keywords: </h5>Qatar; Tobacco control; Smoking cessation; Pharmacist</span><section><a name="sec1"></a><h3>Background</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The leading preventable cause of ill health today is cigarette smoking <a name="d80738e206"></a>[<a onclick="LoadInParent('#B1'); return false;" href="#B1">1</a>]. It is a major risk factor for several causes of death including heart disease, chronic
         lung diseases and lung cancer <a name="d80738e210"></a>[<a onclick="LoadInParent('#B2'); return false;" href="#B2">2</a>]. It kills one in ten adults globally and causes more than 5 million deaths annually.
         If present trends continue, the number of smoking-related deaths is expected to reach
         more than 8 million deaths per year by 2030 <a name="d80738e214"></a>[<a onclick="LoadInParent('#B3'); return false;" href="#B3">3</a>]. The adverse health consequences of tobacco use not only compromise smokers’ quality
         of life, but also entail significant direct and indirect economic costs on society.
         The 2008 World Health Organization (WHO) report states that the global healthcare
         costs attributable to tobacco use reach hundreds of billions of US dollars each year
         <a name="d80738e218"></a>[<a onclick="LoadInParent('#B4'); return false;" href="#B4">4</a>]. Smoking cessation is key to reducing the number of smoking-related diseases and
         deaths. At any age, quitting smoking improves quality of life (QoL) and confers considerable
         health benefits including reduced risk of coronary heart disease, stroke and smoking-related
         cancers <a name="d80738e222"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>],<a name="d80738e227"></a>[<a onclick="LoadInParent('#B6'); return false;" href="#B6">6</a>]. The World Bank suggests that if adult tobacco consumption were to decrease by 50%
         by the year 2020, approximately 180 million tobacco-related deaths could be avoided
         between now and 2050 <a name="d80738e231"></a>[<a onclick="LoadInParent('#B7'); return false;" href="#B7">7</a>]. Health professionals are in an ideal position to encourage smoking cessation. A
         short intervention by them can considerably increase the smoking cessation rate <a name="d80738e235"></a>[<a onclick="LoadInParent('#B8'); return false;" href="#B8">8</a>]. Of all health professionals, pharmacists are the most easily accessed by the public
         and are uniquely situated to initiate behavior change among smokers <a name="d80738e239"></a>[<a onclick="LoadInParent('#B9'); return false;" href="#B9">9</a>]. They can provide education and advice without prior appointment and with no direct
         or additional cost to individuals <a name="d80738e243"></a>[<a onclick="LoadInParent('#B10'); return false;" href="#B10">10</a>]. They regularly interact with patients obtaining medications for smoking-related
         diseases. In addition, the increased availability of pharmacologic smoking cessation
         aids including some formulations of nicotine replacement therapy over the counter
         in pharmacies in many countries gives the pharmacists a distinct opportunity to serve
         as front-line health providers who can play a major smoking cessation role <a name="d80738e247"></a>[<a onclick="LoadInParent('#B11'); return false;" href="#B11">11</a>]. Moreover, available data support the provision of smoking cessation services in
         ambulatory and community pharmacies. Many studies have shown that pharmacists can
         be effective providers of tobacco cessation interventions and can be successful in
         helping patients quit smoking <a name="d80738e252"></a>[<a onclick="LoadInParent('#B12'); return false;" href="#B12">12</a>]-<a name="d80738e256"></a>[<a onclick="LoadInParent('#B20'); return false;" href="#B20">20</a>] and that these pharmacy interventions can be cost-effective or cost-beneficial <a name="d80738e260"></a>[<a onclick="LoadInParent('#B21'); return false;" href="#B21">21</a>]-<a name="d80738e264"></a>[<a onclick="LoadInParent('#B24'); return false;" href="#B24">24</a>]. Additionally, in many countries there is extensive support at the professional level
         for the involvement of pharmacists in smoking cessation. The Canadian Pharmacists
         Association developed a Joint Statement on Smoking Cessation. This statement promotes
         the involvement of health professionals including pharmacists in tobacco prevention
         and cessation <a name="d80738e268"></a>[<a onclick="LoadInParent('#B8'); return false;" href="#B8">8</a>]. The International Pharmaceutical Federation (FIP) issued a statement of policy on
         the role of pharmacists in promoting a tobacco-free future <a name="d80738e272"></a>[<a onclick="LoadInParent('#B25'); return false;" href="#B25">25</a>]. The European Forum adopted a pharmacists’ charter on action against smoking, which
         states that pharmacists should consider smoking cessation as an essential element
         of their professional responsibilities <a name="d80738e277"></a>[<a onclick="LoadInParent('#B26'); return false;" href="#B26">26</a>]. The US Public Health Service published evidence-based clinical guidelines recommending
         that all health care providers, including pharmacists, should offer smoking-cessation
         interventions <a name="d80738e281"></a>[<a onclick="LoadInParent('#B27'); return false;" href="#B27">27</a>]. The American Society of Health-System Pharmacists’ (ASHP) Therapeutic Position Statement
         on the Cessation of Tobacco Use strongly encourages pharmacists as well as other healthcare
         providers to integrate identification of tobacco users and delivery of tobacco-cessation
         interventions into their routine patient care. As per the ASHP statement, these interventions
         should address five key elements of comprehensive tobacco cessation counseling (the
         5 As): (1) asking patients about tobacco use, (2) advising users to quit, (3) assessing
         their readiness to quit, (4) assisting them with quitting using behavior modification
         and smoking cessation medications, and (5) arranging follow-up care. If comprehensive
         tobacco-cessation counseling cannot be provided because of time constraints or practice
         site logistics, pharmacists can use a truncated 5 A model whereby they ask about tobacco
         use, advise tobacco users to quit, and then refer patients to smoking cessation providers
         or programs <a name="d80738e285"></a>[<a onclick="LoadInParent('#B28'); return false;" href="#B28">28</a>].
      </p>
      <p style="line-height:160%">In Qatar, tobacco use is a major public health problem that, in addition to the associated
         morbidity and mortality, constitutes a huge burden on healthcare services. To control
         tobacco use, Qatar has adopted the international approaches recommended by the World
         Health Organization (WHO) and regional plan of Arab countries in the Gulf. These approaches
         are based on three strategies: (1) imposing legislative tobacco control measures,
         for example, banning smoking in enclosed public places and prohibiting selling cigarettes,
         tobacco or its derivatives to anyone less than 18 years old, (2) providing smoking
         cessation services for free in two hospital-based smoking cessation clinics and (3)
         implementing antismoking public awareness activities <a name="d80738e291"></a>[<a onclick="LoadInParent('#B29'); return false;" href="#B29">29</a>]. Despite these approaches, in Qatar up to 37% of adult males currently smoke tobacco
         <a name="d80738e295"></a>[<a onclick="LoadInParent('#B30'); return false;" href="#B30">30</a>] and 13.4% of male school students aged 13 to 15 years smoke cigarettes according
         to the 2007 Global Youth Tobacco Survey <a name="d80738e299"></a>[<a onclick="LoadInParent('#B31'); return false;" href="#B31">31</a>]. Furthermore, smoking-related diseases are the most prevalent in Qatar. Ischemic
         heart disease, as an example, was ranked as one of the leading causes of burden of
         disease in Qatar in 2010 <a name="d80738e303"></a>[<a onclick="LoadInParent('#B32'); return false;" href="#B32">32</a>], and Qatar has a higher age standardized lung cancer incidence rate than many countries
         in the Gulf (8.95 per 100,000) <a name="d80738e307"></a>[<a onclick="LoadInParent('#B33'); return false;" href="#B33">33</a>]. In addition, according to a recent survey done by Weill Cornell Medical College
         in Qatar, at least 1 billion cigarettes are smoked in Qatar each year, averaging 12,000
         per individual, and 65 million US dollars (USD) are spent on cigarettes annually;
         150 million USD are used to cover the healthcare costs of patients affected by smoking-related
         diseases <a name="d80738e312"></a>[<a onclick="LoadInParent('#B34'); return false;" href="#B34">34</a>]. The potential for pharmacist-assisted tobacco cessation is therefore huge and could
         have a considerable impact on smoking rates, prevention of tobacco-related diseases
         and enhancement of public health in Qatar. Around 700 registered pharmacists practice
         in public and private ambulatory care clinics and in community pharmacies in Qatar.
         If each of these pharmacists successfully assists just one tobacco user in quitting
         each month, this would result in more than 8500 quitters annually. However, according
         to a study conducted by Qatar University’s College of Pharmacy and funded by the Qatar
         Foundation under its Undergraduate Research Experience Program (UREP), Qatar’s ambulatory
         and community pharmacists are not fully engaged in smoking cessation activities. Eighty
         percent of Qatar’s ambulatory and community pharmacists rarely, never or sometimes
         ask their patients about their smoking status, and 53% rarely, never or sometimes
         offer smoking cessation counseling to nicotine therapy purchasers. When meeting patients
         who smoke, only 45% of pharmacists discuss the adverse health effects of smoking,
         41% assist them in quitting and 16% arrange follow-up sessions with them to assess
         their progress in quitting smoking. However, more than 85% of pharmacists are interested
         in providing smoking cessation counseling and believe that it is an important activity
         <a name="d80738e316"></a>[<a onclick="LoadInParent('#B35'); return false;" href="#B35">35</a>]. The pharmacists’ perceptions regarding the importance of smoking cessation can be
         transformed into action if a smoking cessation model is provided that these pharmacists
         can use in routine practice. Unfortunately, an intensive, patient-specific program
         of smoking cessation designed exclusively for implementation in community and ambulatory
         pharmacies is not available in Qatar. In addition, evidence regarding the effect of
         such a program is lacking in Qatar.
      </p>
      <p style="line-height:160%">Also important, in addition to the numerous knowledge gaps identified above in relation
         to Qatar, there are also no data on how cost beneficial the running of smoking cessation
         programs like the currently proposed one is, added to a lacking data on the associated
         resource implications in the pharmacy setting from the Qatari perspective.
      </p>
      <h4>Study objectives</h4>
      <p style="line-height:160%">This proposal describes a study that is currently being implemented in eight public
         and private ambulatory clinic pharmacies in Qatar. Our hypothesis is that a patient-specific
         structured smoking cessation program delivered by smoking cessation-trained ambulatory
         pharmacists would be significantly more effective in helping smokers stop smoking
         and achieving long-term smoking abstinence than brief unstructured pharmacist-delivered
         advice.
      </p>
      <p style="line-height:160%">We also hypothesize that quitting smoking would lead to significant improvement in
         health-related quality of life.
      </p>
      <p style="line-height:160%">The study objectives are:</p>
      <p style="line-height:160%"> Primary: To test the effect of a face-to-face structured patient-specific smoking
         cessation program delivered by trained ambulatory pharmacists on smoking cessation
         rates in Qatar
      </p>
      <p style="line-height:160%"> Secondary: To assess the change in health-related quality of life in quitters vs.
         non-quitters
      </p>
      <p style="line-height:160%"> Secondary: To explore the resource utilization of implementing the smoking cessation
         program as delivered by the ambulatory pharmacists in Qatar. This is a cost analysis
         of the overall cost of running the proposed patient-specific cessation program, including
         cost-effectiveness analyses.
      </p>
   </div>
</section>
<section><a name="sec2"></a><h3>Methods/design</h3>
   <div class="collapsible-content">
      <h4>Study design</h4>
      <p style="line-height:160%">The study is a prospective randomized controlled trial comparing the effectiveness
         of a face-to-face structured patient-specific smoking cessation program conducted
         by trained ambulatory pharmacists versus brief unstructured pharmacist-delivered advice
         on smoking cessation rates.
      </p>
      <h4>Study sites</h4>
      <p style="line-height:160%">The study is implemented in eight public and private ambulatory pharmacies in the
         State of Qatar. These pharmacies are located within large ambulatory clinics that
         serve a large proportion of the Qatar population. To prevent cross contamination with
         the study, none of these clinics has established smoking cessation programs. Each
         study pharmacy is staffed by at least three pharmacists. Two pharmacists from each
         pharmacy are invited to participate in the study. The study is taking place in a semiprivate
         area in the pharmacy. This area is secluded enough to ensure adequate patient confidentiality.
      </p>
      <h4>Study pharmacists’ training</h4>
      <p style="line-height:160%">Prior to starting the study, each study site pharmacist was sent a copy of the study
         methodology along with a written literature review on smoking cessation and asked
         to study the material.
      </p>
      <p style="line-height:160%">Two to three weeks after receipt of the material, the study pharmacist attended a
         2-day (8 h/day) smoking cessation training workshop that was organized by the Hamad
         Medical Corporation (HMC) smoking cessation clinic team and Qatar University (QU)
         College of Pharmacy.
      </p>
      <p style="line-height:160%">The training team consisted of Dr. Ahmed al Mulla (Public Health and Disease Control
         Consultant and HMC smoking cessation clinic head), Dr. Maguy El Hajj (Study Principal
         Investigator/Assistant Professor and CPP Chair at QU College of Pharmacy), Dr. Nadir
         Kheir (Associate Professor and CPPD coordinator at QU College of Pharmacy) and Dr.
         Mohamad Haniki Nik Mohamed [Deputy Dean (Academic Affairs) in Kulliyyahof Pharmacy
         at the International Islamic University Malaysia (IIUM)]. Dr. Haniki is considered
         an international authority in the area of substance abuse, including cigarette smoking.
      </p>
      <p style="line-height:160%">The HMC smoking cessation clinic is one of the smoking cessation facilities in Qatar.
         The clinic is run by highly qualified smoking cessation consultants and has a smoking
         cessation success rate of 40%. In addition to offering smoking cessation treatment,
         this clinic contributes to community education on the dangers of smoking among the
         citizens and residents of Qatar and provides smoking-related lectures and seminars
         for all age groups in the state <a name="d80738e366"></a>[<a onclick="LoadInParent('#B36'); return false;" href="#B36">36</a>].
      </p>
      <p style="line-height:160%">The general objective of this workshop is to provide the study pharmacists with enough
         smoking cessation knowledge and the necessary skills and tools to assess and treat
         smokers. A smoking cessation training manual that was developed by the study training
         team is extensively used in the workshop. This manual is also used as an on-site resource
         by the study pharmacists in their smoking cessation program.
      </p>
      <p style="line-height:160%">The workshop covered the following: smoking epidemiology and risks, benefits of quitting,
         a transtheoretical model for behavior change as applied to smoking cessation, the
         necessary elements for documentation in the patient smoking cessation profile, behavioral
         modification techniques, classification of smokers according to their stage of change
         (5 stages: precontemplation, contemplation, preparation, action and maintenance),
         nicotine replacement therapy (NRT: nicotine patch, lozenge and gum), patient counseling
         techniques, development of a personalized action plan, use of the exhaled carbon monoxide
         test, detailed instructions on the program methodology and other needed elements.
      </p>
      <p style="line-height:160%">In addition, the pharmacists’ training workshop included training the pharmacists
         on how to follow the study protocol exactly. The study team walked the pharmacists
         through the study protocol including how to randomly allocate participants to the
         intervention and control groups, how to deliver the intervention and how to deal with
         control patients.
      </p>
      <p style="line-height:160%">During the training workshops, emphasis was also placed on the importance of behavioral
         and lifestyle modifications. Pharmacists were instructed to encourage smokers who
         are anticipating quitting to identify the situations that may increase their risk
         of smoking such as having smokers within the household or at the workplace as well
         as getting into stressful situations. After identifying these situations, the pharmacists
         were provided with information they could give to smokers about strategies to improve
         coping including lifestyle changes to decrease stress and improve QoL, removing visual
         cues for smoking and staying away from these situations that normally make patients
         want to smoke <a name="d80738e378"></a>[<a onclick="LoadInParent('#B37'); return false;" href="#B37">37</a>]. In addition, the pharmacists were trained to provide the smokers with information
         about what to expect during quit attempts and to address any individual concerns that
         the smokers may have <a name="d80738e382"></a>[<a onclick="LoadInParent('#B38'); return false;" href="#B38">38</a>]. Furthermore, they were advised to encourage the smokers to notify family and friends
         of the plan to quit and to ask for their support <a name="d80738e386"></a>[<a onclick="LoadInParent('#B37'); return false;" href="#B37">37</a>].
      </p>
      <p style="line-height:160%">Participant counseling and interviewing techniques were also part of the training
         workshops. To enhance learning, the pharmacists applied these techniques using patient
         role-plays in small groups. Topics that were reviewed included counseling skills,
         verbal and nonverbal communication skills including use of empathy and active listening,
         use of open-ended and priming questions, verification of patient understanding, overcoming
         of communication barriers, communication with difficult patients, communication with
         patients not interested in discussing smoking cessation and use of strategies to improve
         medication adherence.
      </p>
      <p style="line-height:160%">Documentation was an important element of the workshop. The pharmacists were trained
         to document the patient’s smoking, medical and medication history, basic demographic
         characteristics, staging, assessment, education, counseling, follow-up and the personalized
         action plan to quit smoking. In addition, they were instructed on how to fill in the
         Fagerstrom test for nicotine dependence (FTND). The FTND is a six-item questionnaire
         designed to assist the healthcare professional in determining a patient’s degree of
         nicotine dependence <a name="d80738e394"></a>[<a onclick="LoadInParent('#B39'); return false;" href="#B39">39</a>]. This questionnaire has already been used in smoking-related research studies in
         the Middle East area <a name="d80738e398"></a>[<a onclick="LoadInParent('#B40'); return false;" href="#B40">40</a>],<a name="d80738e402"></a>[<a onclick="LoadInParent('#B41'); return false;" href="#B41">41</a>]. Furthermore, they were instructed to measure the smoker’s health-related QoL using
         the Smoking Cessation Quality of Life (SCQOL) questionnaire. This instrument was developed
         and validated for use in smoking cessation <a name="d80738e406"></a>[<a onclick="LoadInParent('#B42'); return false;" href="#B42">42</a>],<a name="d80738e410"></a>[<a onclick="LoadInParent('#B43'); return false;" href="#B43">43</a>] and has already been used in previous studies that tested the effectiveness of a
         pharmacist-delivered smoking cessation program <a name="d80738e415"></a>[<a onclick="LoadInParent('#B16'); return false;" href="#B16">16</a>]. This questionnaire tackles a total of 13 general and smoking cessation-specific
         quality-of-life domains including physical functioning, role-physical, bodily pain,
         general health, vitality, social functioning, role-emotional, mental health, social
         interactions, self-control, sleep, cognitive functioning and anxiety <a name="d80738e419"></a>[<a onclick="LoadInParent('#B43'); return false;" href="#B43">43</a>].
      </p>
      <h4>Study/program marketing</h4>
      <p style="line-height:160%">The study pharmacists were trained to recognize many opportunities for the promotion
         of the smoking cessation program as possible. For example, when dispensing prescriptions,
         the study pharmacists were encouraged to ask patients about smoking and to tell them
         about the smoking cessation program. In addition, study site pharmacists displayed
         posters and leaflets in their pharmacy describing the smoking cessation program. Furthermore,
         the general practitioners and dentists practicing in the study ambulatory clinics
         were sent letters inviting them to refer their patients who are interested in quitting
         to the study pharmacies.
      </p>
      <h4>Screening and eligibility criteria</h4>
      <p style="line-height:160%">Interested smokers meet with the study pharmacists. The study pharmacists use a scripted
         questionnaire to screen smokers in order to assess their eligibility for the study.
         Eligible participants are patients aged 18 years and older who currently smoke one
         or more cigarettes daily for 7 days, are motivated to quit, i.e., in the preparation
         stage of the stage-of-change model, able to communicate in Arabic or English, and
         are willing to and capable of attending the scheduled sessions at the study pharmacies.
         The motivation to quit is determined by the pharmacist using the transtheoretical
         model of behavior change <a name="d80738e435"></a>[<a onclick="LoadInParent('#B44'); return false;" href="#B44">44</a>]. Smokers in the precontemplation or contemplation stages are advised to quit, are
         provided with educational materials regarding tobacco cessation and the health benefits
         of quitting, and are encouraged to come back to the pharmacy when they feel they are
         ready to commit to quitting smoking.
      </p>
      <p style="line-height:160%">Exclusion criteria are (1) use of other nicotine or tobacco products and (2) current
         use or use in the last 30 days of smoking cessation aids or medications, (3) planning
         to leave Qatar in the next 12 months, (4) presence of any major medical condition
         that would prevent use of the nicotine replacement therapy including hypersensitivity
         to the products, history of or recent myocardial infarction, life-threatening arrhythmias,
         severe or worsening angina, uncontrolled hypertension and temporomandibular joint
         disease (in case of nicotine gum), (5) pregnancy and (6) psychiatric illness or another
         debilitating condition that would interfere with participation in the study.
      </p>
      <h4>Study enrollment</h4>
      <p style="line-height:160%">Following the completion of the screening procedure, the study pharmacist gives the
         eligible participant pertinent background information on the program, explaining what
         his or her participation would involve (including potential benefits, risks, inconveniences,
         discomforts), and his or her right to confidentiality. In order to enroll in the study,
         the interested participant is asked to sign an approved consent form. Once the consent
         form is signed, the pharmacist collects the participant’s contact information and
         sets an appointment with him or her at a date and time that is suitable for both of
         them.
      </p>
      <h4>Initial appointment and randomization</h4>
      <p style="line-height:160%">One to two days before his or her scheduled appointment, the study pharmacist contacts
         the enrolled participant to remind him or her about the appointment. At this initial
         appointment, which takes around 30 min, the study pharmacist first collects the participant’s
         sociodemographic characteristics, current medical problems and medications, smoking
         history (i.e., number of cigarettes per day, duration of smoking, previous quit attempts,
         smoking habits of other family members and the participant’s reasons for wanting to
         quit smoking) and vital signs (i.e., blood pressure and pulse). In addition, the pharmacist
         assesses the smoker’s level of nicotine dependence using the Fagerstrom Test for Nicotine
         Dependence and measures his or her baseline exhaled carbon monoxide (CO) level using
         the exhaled CO test. Furthermore, the pharmacist administers the smoking cessation
         quality-of-life (SCQOL) questionnaires. After baseline data collection, the smoker
         is randomly assigned to either the intervention group or the control group. Randomization
         is already anonymously preset by the study statistician for each study pharmacist.
         According to the participant number and the preset list, the participant will be randomized
         to the intervention or control group. A new appointment is set with the participants
         assigned to the intervention group. Participants assigned to the control group receive
         brief unstructured smoking cessation advice as outlined below. Participants in both
         groups do not pay for their participation.
      </p>
      <h4>Intervention group</h4>
      <p style="line-height:160%">Participants assigned to the treatment group participate in a face-to-face four-session
         program at the pharmacy delivered by the study pharmacist at 2-4-week intervals over
         8 weeks. The sessions are set at a date and time that are convenient for both the
         pharmacist and participant.
      </p>
      <h4>First session</h4>
      <p style="line-height:160%">The first session is time-intensive, taking around 30 min. In this session, the study
         pharmacist facilitates the participant’s preparation to quit. The participant selects
         a quit date within the next 2-4 weeks. Based on the transtheoretical model of change,
         this would give him or her time to get prepared to enter the action stage on the quit
         date.
      </p>
      <p style="line-height:160%">The pharmacist discusses the benefits of smoking cessation with the participant and
         provides him or her with tailored behavioral and lifestyle strategies. These strategies
         take into consideration the participant behaviors, values and beliefs. For example,
         if the smoker states that the hardest time would be at work when others are taking
         breaks to smoke, the pharmacist may suggest ways to spend the time during breaks.
         As outlined under the training section, the pharmacist also provides the participant
         with information about what to expect during the quit attempt with suggestions to
         cope with the early days of quitting. In addition, the pharmacist encourages the participant
         to seek family support during the attempt.
      </p>
      <p style="line-height:160%">To prevent nicotine withdrawal symptoms, the participant is also offered, without
         cost, nicotine replacement therapy (NRT) as a patch or lozenge depending on his or
         her previous experience, preference and adverse effect profile. Other NRT dosage forms,
         e.g., an inhaler, nasal spray and sublingual tablets, are not available in Qatar.
         The gum is usually not tolerated by patients. The participant is not offered the other
         smoking cessation aids, including bupropion and varenicline, as they require a prescription
         in order to be dispensed in Qatar. Before dispensing the NRT, the study pharmacist
         ensures that the participant does not have any contraindications to nicotine therapy
         and is not taking any medication that would interact with NRT. The NRT is started
         on the participant’s intended quit date. Patient counseling about NRT is provided
         to each participant regarding the dosage, administration, scheduling, duration of
         therapy, adverse effects, interactions and proper disposal.
      </p>
      <p style="line-height:160%">Participants who take the nicotine patch start at 21 mg if they smoke ten cigarettes
         or more per day. Otherwise, they receive a 14-mg patch. Both patches are continued
         for 6 weeks before being tapered. The 21-mg patch is decreased to 14 mg, continued
         for 2 weeks and decreased to 7 mg for a final 2 weeks. Patients who start with the
         14-mg patch are tapered to 7 mg for a final 2 weeks <a name="d80738e471"></a>[<a onclick="LoadInParent('#B45'); return false;" href="#B45">45</a>]. Participants who take the nicotine lozenge use the 1-mg pieces. It is continued
         for 6 weeks as one lozenge every 1-2 h before being tapered. Then the participant
         takes one lozenge every 2-4 h for weeks 7 to 9, then one lozenge every 4-8 h for week
         10-12 <a name="d80738e475"></a>[<a onclick="LoadInParent('#B46'); return false;" href="#B46">46</a>].
      </p>
      <p style="line-height:160%">A personalized action plan is created by the pharmacist to document the participant’s
         quit date, nicotine replacement therapy dosage schedule and counseling, suggested
         behavioral and lifestyle strategies, and date/time of the next appointment. This plan
         is signed by both the participant and pharmacist.
      </p>
      <h4>Follow-up sessions</h4>
      <p style="line-height:160%">The first follow-up session is scheduled 1 week after of the participant’s quit day
         and takes around 20 min. In this session, the pharmacist determines the participant’s
         smoking status, measures his or her blood pressure/pulse/exhaled CO level, and assesses
         the NRT tolerability. If the patient succeeds in quitting, the pharmacist provides
         reinforcement and addresses problems associated with quitting such as managing withdrawal
         symptoms, coping with cravings, relieving stress, and managing fear of weight gain
         and of change in relationships with other smoking friends or relatives. If the participant
         fails to quit smoking, the pharmacist carefully reviews the participant’s experience
         during the attempt to quit and works through the identified problems. If the participant
         does not tolerate the NRT side effects (e.g., his or her blood pressure or heart rate
         increases), the pharmacist asks the participant to stop the NRT and refers him or
         her to the HMC smoking cessation clinic for further smoking cessation support. This
         participant is no longer enrolled in the study.
      </p>
      <p style="line-height:160%">The second follow-up session is scheduled 2 weeks after the first follow-up session.
         The third follow-up session is set at 4 weeks after the second follow-up session.
         These sessions take no more than 10 or 15 min each. In these sessions the pharmacist
         assesses the participant’s smoking status, blood pressure/heart rate/exhaled CO level
         and NRT tolerability and provides NRT refills. In addition, he or she focuses on maintenance
         of smoking abstinence with cognitive-behavioral strategies to prevent relapse. The
         pharmacist documents any action taken by him/her at each follow-up session. After
         the third follow-up session, all participants are instructed to call or visit the
         pharmacy for questions or to receive additional support as needed. For more information
         on participant flow during the study, see Figure&nbsp;<a name="d80738e488"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/65/figure/F1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/65/figure/F1">1</a>.
         
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/65/figure/F1','F1',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/65/figure/F1"><img align="top" src="/content/figures/s13063-015-0570-z-1.gif" alt="thumbnail" class="thumbnail"><strong>Figure 1.</strong></a> <strong>Participant flow during the study.</strong></div></div>
      <h4>Control group</h4>
      <p style="line-height:160%">Participants in the control group receive 5-10 min of unstructured brief smoking cessation
         counseling by the pharmacist (emulating current practice). In addition, they are provided
         with educational materials about smoking cessation and are offered nicotine replacement
         therapy (NRT). Before dispensing the NRT, the study pharmacist ensures that the participant
         does not have any contraindications to nicotine therapy and is not taking any medication
         that would interact with NRT. The choice of the NRT dosage form (patch or lozenge)
         depends on the participant’s previous experience, preference and adverse effect profile.
         The NRT dosage schedule and duration of therapy are similar to those in the intervention
         group. Control participants are not asked to attend any follow-up sessions.
      </p>
      <p style="line-height:160%">The education materials address the following topics: the adverse effects of smoking,
         benefits of smoking cessation, the methods of quitting, setting the quit date, coping
         with nicotine withdrawal symptoms, getting emotional and social support, and monitoring
         the blood pressure and pulse when using NRT and avoiding relapse.
      </p>
      <p style="line-height:160%">The study team invests a good deal of time orienting the study pharmacists on their
         role and training them on how to deal with the control and intervention groups. Part
         of that orientation is on how ‘not’ to provide any intervention to the control subset
         of smokers.
      </p>
      <h4>Study piloting</h4>
      <p style="line-height:160%">Study pharmacists were provided with assistance in setting up the study pharmacies
         and given some time to familiarize themselves with the study protocol prior to commencement
         of the study. Then each pharmacist was asked to pilot the study in the presence of
         the study team. Piloting occurred by screening/recruiting around four patients in
         each site and by implementing the study protocol. Feedback was provided as required
         to the study pharmacists on the quality of patient counseling, patient education and
         documentation. Very minor adjustments or refinements were made to the study protocol
         and study tools including the patient consent form, Fagerstrom test for nicotine dependence
         (FTND) and smoking cessation quality-of-life (SCQOL) questionnaire as needed.
      </p>
      <h4>Continuous quality improvement and evaluation plan</h4>
      <p style="line-height:160%">At all stages of the study implementation, the study pharmacists are closely supervised
         by the study team. Supervision is through several mechanisms including meetings, communication
         and site visits.
      </p>
      <h4>Meetings</h4>
      <p style="line-height:160%">Regular meetings are invaluable for high-quality supervision. Meetings are used to
         guide the project toward its objectives through team involvement. Bi- or triweekly
         meetings involving all the team members including the study pharmacists are held.
         In these meetings, study harmacists summarize their activities during the previous
         2-3 weeks, and the study team offers them constructive feedback, acknowledges their
         input and suggests new directions to them. In addition, ad-hoc meetings are conducted
         between the study pharmacists and the study team where necessary to address any irregular
         issues that might arise.
      </p>
      <h4>Communication</h4>
      <p style="line-height:160%">The study team members are in direct touch with each other and with the study pharmacists
         through electronic communication such as emails.
      </p>
      <h4>Site visits</h4>
      <p style="line-height:160%">To maintain quality control in the smoking cessation study pharmacies, the study team
         visits each study pharmacy at least once every 2 to 3 weeks to monitor data collection,
         check protocol adherence, ensure the consistency of program delivery, address any
         queries that the study pharmacists might have in implementing the study, review patients’
         folders for appropriate documentation, provide any on-site support required and provide
         individual pharmacists with feedback on their performance.
      </p>
      <p style="line-height:160%">Supervision is crucial to:</p>
      <p style="line-height:160%"> Orient study pharmacists to the study’s objectives and methodology and to their role
         in the study
      </p>
      <p style="line-height:160%"> Monitor and follow-up the progress of the study</p>
      <p style="line-height:160%"> Tackle any issues or concerns that might arise with the study pharmacists while the
         study is executed
      </p>
      <p style="line-height:160%"> Share study updates</p>
      <p style="line-height:160%"> Motivate and support the study pharmacists</p>
      <p style="line-height:160%"> Ensure adherence to the study protocol in the different study sites</p>
      <p style="line-height:160%"> Ensure standardization of study implementation in the different study sites</p>
      <h4>Overview of utilization cost</h4>
      <p style="line-height:160%">A comparative overview of the cost of resource utilization (economic analysis) will
         be undertaken for the study arms in this study.
      </p>
      <h4>Model inputs and cost determination</h4>
      <p style="line-height:160%">This pharmacoeconomic analysis will be based on extrapolating data on resources from
         the randomized controlled trial; these data will be collected prospectively. Prospective
         data collection enhances the accuracy and robustness of data and limits bias.
      </p>
      <p style="line-height:160%">The economic analysis is performed from a social perspective. Direct medical costs
         will be evaluated to the best available, including in relation to NRT, CO monitoring
         tests and salaries. Direct nonmedical costs will also be evaluated and will include
         participants’ travel costs to pharmacies (e.g., taxi) and the paperwork and forms.
         The indirect costs will be accounted for as well, in relation to lost productivity
         (if any), whether for participants or any unpaid caregivers that participants utilize.
         Important is that any protocol-driven costs (e.g., researchers salaries) will be excluded
         from the analysis.
      </p>
      <p style="line-height:160%">The monetary value of resources will be collected from internal sources at the Qatari
         clinics. It is worth noting that costs involved in this study will be based on wholesale
         prices, as paid by clinics.
      </p>
      <p style="line-height:160%">All calculated costs will be in Qatari Riyal, adjusted for the financial year 2015-2016,
         utilizing the Qatari Health Consumer Price Index as appropriate, and no discounts
         will be applied given the short timeframe of the analysis.
      </p>
      <p style="line-height:160%">The economic evaluation will be undertaken via decision analytic modeling, where a
         decision tree will be structured to follow the different options and consequences
         in the management pathways. For each of the participants, the proposed model may include
         five possible treatment outcomes depending on whether participants quit smoking, and
         if they do, after what duration. Smokers will be initially assigned to one of two
         pathways depending on whether they quit smoking at enrollment. Smokers who do not
         quit at enrollment will be further followed until assigned to one of two pathways,
         depending on whether the smoker quits smoking after 3 months or not. If not, smokers
         will be followed up until further assigned to one of two pathways, based on whether
         they quit smoking after 6 months or not. Those who do not quit by then will be followed
         up until assigned to one of two pathways depending on whether they quit at 12 months
         of follow-up or not, which will be the end of follow-up in any case. Smokers who quit
         at enrollment or after 3, 6 or 12 months will each be followed up separately until
         the end of the study. Based on this, in addition to data on resources consumed and
         their monetary values, the model will generate a weighted average cost for patient
         cessation and quality-of-life adjustment. As per the general decision analysis principles,
         this will be calculated as the sum-product of the costs of the management outcomes
         and the respective probabilities.
      </p>
      <p style="line-height:160%">The costs of managing the single episode of smoking cessation will be compared among
         different management options and against budgeted costs of clinics/government institutions.
      </p>
      <h4>Sensitivity analysis</h4>
      <p style="line-height:160%">The goal of sensitivity analysis is to indicate the robustness of the evaluation conclusion
         against any potential variations in the model inputs. Deterministic and probabilistic
         sensitivity tests will be produced by modifications on the base case values of several
         key variables, in relevance to costs and probabilities, to evaluate the robustness
         of the study economic outcome. Base case values will be substituted by the highest
         and lowest values within a reasonable range of values. Where a substitution changes
         the study economic conclusion, more values within the range will replace the base
         case value. This will be repeated until the exact variable value that changes the
         study outcome is identified. Reporting this as part of the study results not only
         indicates the robustness of results, but also boosts the generalizability of them
         when being interpreted by decision makers in other settings, with different model
         inputs, e.g., different resource prices.
      </p>
      <p style="line-height:160%">Uncertainty analysis, by means of Monte Carlo simulation, will be performed via the
         @Risk-5.0® analysis tool (Palisade Corp., NY, USA) to investigate the likelihood (probability)
         of a therapy’s economic advantage. Monte Carlo is a method whereby simulated input
         values, chosen randomly across a range of probability distributions of a model input,
         are added into the model. The model is run for each simulated input, resulting in
         a range of outputs characterizing the output uncertainty. Based on this, a distribution
         of “cost savings” will be generated, indicating the probability of one management
         option to have an economic advantage over another.
      </p>
      <h4>Ethical considerations and confidentiality</h4>
      <p style="line-height:160%">The study protocol and all associated measures, consent forms and recruitment procedures
         obtained ethical approval by Qatar University (QU) and Hamad Medical Corp. (HMC) institutional
         review boards (QU-IRB 76/11 and HMC 11113/11). All the participants’ folders are stored
         in a password-protected database on the site laptop. Only the study pharmacist can
         access these folders. In addition, all data are retained in a password-protected database
         maintained along with all related study documentation in a locked cabinet at QU College
         of Pharmacy.
      </p>
      <h4>Outcome measures</h4>
      <p style="line-height:160%">The study research assistants will call the study participants in the intervention
         and control groups to complete the assessment. To avoid any bias in data collection,
         the research assistants will be blinded to the participant group allocation.
      </p>
      <p style="line-height:160%">They will measure the following outcome variables at 3, 6 and 12 months after the
         start of the study (i.e., the time of the participant’s enrollment in the study):
      </p>
      <p style="line-height:160%"> Self-reported 7-day point prevalence abstinence, defined as having smoked no cigarettes
         for the previous 7 days at 3, 6 and 12 months
      </p>
      <p style="line-height:160%"> Self-reported 30-day point prevalence abstinence defined as having smoked no cigarettes
         in the last 30 days at 3, 6 and 12 months
      </p>
      <p style="line-height:160%"> Self-reported continuous abstinence defined as having smoked no cigarettes since
         quit day at 3, 6 and 12 months
      </p>
      <p style="line-height:160%"> Smoking abstinence as objectively verified by the CO exhaled test at 12 months</p>
      <p style="line-height:160%"> Mean change in health-related quality-of-life score from baseline at 3, 6 and 12
         months for quitters vs. non-quitters
      </p>
      <p style="line-height:160%"> Overall costs of interventions as studied, including those of utilization for individual
         recourses consumed
      </p>
      <p style="line-height:160%"> Average and incremental cost-effectiveness ratio of the study smoking cessation intervention</p>
      <p style="line-height:160%">To objectively determine long-term abstinence, at 12 months, participants who will
         self-report not smoking for the previous 7 days will be invited to come to their study
         clinic to measure their exhaled CO level. The clinic nurse who is responsible for
         measuring the exhaled CO level will be blinded to the study participant group. Participants
         will be considered abstinent if they register less than 6 ppm on the test. Interpretation
         of the CO test results will be made carefully taking into consideration time since
         last smoke, time of the day the test is done and other factors.
      </p>
      <p style="line-height:160%">Exhaled carbon monoxide is a well-known indicator of cigarette smoking. But because
         of its short half-life (5-6 h), it only indicates very recent smoking exposure or
         abstinence. On the other hand, as a result of its relatively long half-life, cotinine
         can detect nicotine exposure for up to 1 week. However, the use of any NRT formulation
         can trigger a false-positive urinary cotinine test. Therefore, as it is not expensive
         and is noninvasive, and it gives the results in a timely manner, the exhaled carbon
         monoxide test is commonly used in most smoking cessation clinical trials <a name="d80738e624"></a>[<a onclick="LoadInParent('#B47'); return false;" href="#B47">47</a>].
      </p>
      <h4>Data analysis</h4>
      <p style="line-height:160%">The CONSORT guidelines will be followed when analyzing the study data. Demographics
         and other variables related to smoking and quality of life will be summarized using
         frequency distributions (for categorical variables) and means with standard deviations
         (for numeric variables) and will be compared between the two study arms using the
         chi-squared test (or alternatively the Fisher’s exact test for small cell counts)
         for categorical variables and the independent <em>t</em>-test (or alternatively the Wilcoxon rank sum test for non-normally distributed variables)
         for numerical variables.
      </p>
      <p style="line-height:160%">The main outcome will be continuous abstinence at 12 months as self-reported and verified
         by the CO test. The percentages of participants achieving the main outcome will be
         computed and compared between the two groups using the chi-squared test. Moreover,
         the difference in the proportions of continuous abstinence at 12 months between the
         two study arms (with 95% confidence intervals) will be computed along with the number
         needed to treat. Multiple logistic regression will be used to obtain the odds ratio
         of the main outcome between the two study arms adjusting for any imbalances in demographics
         or other baseline smoking-related variables. Moreover, mixed effects logistic regression,
         with pharmacy-level random effect, will be considered to adjust for the possible pharmacy
         effect if it existed. The intent-to-treat principal will be used in the analysis whereby
         participants who will be lost to follow-up will be classified as smokers and included
         in the main analysis. This includes those who were removed from the study because
         they could not tolerate NRT side effects. A sensitivity analysis following that of
         Borelli, Hogan et al. will be done where the outcome has three possible categories:
         abstinence, no abstinence and dropout <a name="d80738e639"></a>[<a onclick="LoadInParent('#B48'); return false;" href="#B48">48</a>]. The suggested multinomial model will allow assessing factors affecting abstinence
         as well as factors affecting dropout. This will aid in understanding who might need
         more support during the intervention. Similar analyses for the primary outcome will
         be done at 3 and 6 months (but do not include verification of abstinence using CO
         tests).
      </p>
      <p style="line-height:160%">To assess the participants’ health-related quality of life, SCQOL (smoking cessation
         quality of life) ratings for each question will be translated into scores. A total
         health-related quality of life score and a domain-specific score will be calculated
         at baseline, 3 months, 6 months and 12 months for each participant in the intervention
         and control groups. The change in the total and domain-specific quality-of-life score
         from baseline will be calculated for each participant at 3, 6 and 12 months and analyzed
         using linear mixed models, which will include the quitting (quitters and non-quitters)
         factor and time factor (at 3, 6 and 12 months) and their interaction.
      </p>
      <p style="line-height:160%">There is no interim analysis planned for this trial. Statistical analyses will be
         conducted using the Statistical Package of Social Sciences (IBM-SPSS®), version 21.
         In all analyses, the level of significance will be set at 5%.
      </p>
      <h4>Sample size calculation</h4>
      <p style="line-height:160%">For a priori sample size calculation, we assumed a 7-day point prevalence abstinence
         at 12 months of 3% for the control group and 15% for the intervention group based
         on the results of one of the previous studies that assessed the effect of a pharmacist-run
         smoking cessation program <a name="d80738e653"></a>[<a onclick="LoadInParent('#B12'); return false;" href="#B12">12</a>]. With a two-sided alpha of 5% and 90% power, a minimum sample size of 118 participants
         was estimated for each group. This sample size was not adjusted for the potential
         correlation between outcomes of patients within each clinic since this is not a clustered
         randomized clinical trial, but in this study patients within each clinic are randomized
         to the two intervention groups, and correlations, if they exist, will be very small;
         their effect on the power of the study is negligible <a name="d80738e657"></a>[<a onclick="LoadInParent('#B15'); return false;" href="#B15">15</a>]. The project has a total of 17 study pharmacists. Each study site is expected to
         enroll at least 30 participants (15 participants in the intervention group and 15
         participants in the control group). The recruitment period is over 12 months (48 weeks).
         Recruiting at least 30 participants at each study site is considered feasible given
         that at least 100 patients visit each pharmacy per day. Assuming each study site will
         recruit 1 participant every week, the 30 needed participants will be recruited in
         30 weeks (approximately 8 months). An extra 16 weeks of recruitment time is given
         to study pharmacists to account for workload, holidays and sickness.
      </p>
   </div>
</section>
<section><a name="sec3"></a><h3>Discussion</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">This study is the first randomized controlled trial conducted within Qatar and the
         Middle East (ME) to test the effect of a pharmacist-delivered smoking cessation program
         on smoking cessation rates. Furthermore, it is the first study in Qatar to assess
         the change in health-related quality of life after quitting smoking.
      </p>
      <p style="line-height:160%">Having the economic analysis component in this study is also of unique significance.
         To our knowledge, there are no economic studies that have evaluated the economics
         of a smoking cessation program in Qatar or the region. This component is important
         as in settings where resources are scarce, proving that an intervention brings a good
         return to the investment can be as important as proving the intervention effective.
      </p>
      <p style="line-height:160%">Indeed, in consideration of limited resources and tight departmental budgets, the
         additional spending associated with any of the study options should be examined. This
         will be performed through determining the management option that yields benefits that
         are associated with most health costs savings. For example, the structured program
         in this study is expected to have a favorable comparative effect profile. But if the
         value that is associated with these advantages is not high enough, having the structured
         program in settings may not be the priority practice to implement. Here, the current
         study provides a great opportunity for such analysis, seeing that randomized controlled
         trials are the ideal source of data (i.e., highest level evidence) to be used in the
         construction of economic analyses.
      </p>
      <p style="line-height:160%">This study will be of significance to Qatar, the ME and to some extent the world.
         It will advance knowledge about the role that the ambulatory pharmacists in Qatar
         and possibly in the ME can play in smoking cessation. It will show to what extent
         these pharmacists would be effective in helping smokers quit smoking. This would be
         important for Qatar and the ME given the high number of cigarette smokers in these
         countries <a name="d80738e673"></a>[<a onclick="LoadInParent('#B49'); return false;" href="#B49">49</a>]. This study will also help in comparing the effect of pharmacist-delivered smoking
         cessation programs in Qatar with the effect of pharmacist-delivered smoking cessation
         programs in other countries. Many previous studies conducted in Australia, Europe
         and the USA have demonstrated the effectiveness of pharmacist-run smoking cessation
         programs <a name="d80738e677"></a>[<a onclick="LoadInParent('#B12'); return false;" href="#B12">12</a>]-<a name="d80738e681"></a>[<a onclick="LoadInParent('#B20'); return false;" href="#B20">20</a>]. Extrapolating the results of these studies to Qatar and the ME is not readily applicable.
         The pharmacy practice environment in these countries differs from that in Qatar. The
         pace of improvement in ambulatory pharmacy practice in Qatar, as other ME countries,
         is slow. Except for a few cognitive and patient-oriented activities, ambulatory pharmacists’
         job is limited to prescription processing and medication dispensing <a name="d80738e685"></a>[<a onclick="LoadInParent('#B50'); return false;" href="#B50">50</a>]. Nevertheless, Qatar’s pharmacists are increasingly interested in defining a well-recognized
         vocation for themselves in today’s healthcare system and in moving their focus from
         pharmaceutical products to patients. This study will be of potential significance
         to ambulatory pharmacists in Qatar. It will put them in a broader perspective than
         the product-dispensing context. It will promote their role as public health educators
         and accessible sources of health information. Ambulatory pharmacists are an essential
         part of the healthcare system in Qatar and are an existing workforce that needs to
         be given the opportunity to contribute to patient care. By direct involvement of these
         pharmacists in smoking cessation, this study will help in improving their professional
         role and in shifting it to a more patient-centered focus and will assist them in having
         better integration into the healthcare team in Qatar.
      </p>
   </div>
</section>
<section><a name="sec4"></a><h3>Trial status</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">Patient recruitment is currently ongoing.</p>
   </div>
</section>
<section><a name="sec5"></a><h3>Abbreviations</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">WHO: World Health Organization</p>
      <p style="line-height:160%">QoL: Quality of life</p>
      <p style="line-height:160%">FIP: International Pharmaceutical Federation</p>
      <p style="line-height:160%">ASHP: American Society of Health-System Pharmacists</p>
      <p style="line-height:160%">UREP: Undergraduate Research Experience Program</p>
      <p style="line-height:160%">HMC: Hamad Medical Corporation (HMC)</p>
      <p style="line-height:160%">QU: Qatar University</p>
      <p style="line-height:160%">CPP: Clinical Pharmacy and Practice</p>
      <p style="line-height:160%">CPPD: Continuing professional pharmacy development</p>
      <p style="line-height:160%">NRT: Nicotine replacement therapy</p>
      <p style="line-height:160%">CO: Carbon monoxide</p>
      <p style="line-height:160%">FTND: Fagerstrom test for nicotine dependence</p>
      <p style="line-height:160%">SCQOL: Smoking cessation quality of life</p>
      <p style="line-height:160%">SPSS: Statistical Package of Social Sciences</p>
      <p style="line-height:160%">ME: Middle East</p>
   </div>
</section>
<section><a name="sec6"></a><h3>Competing interests</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The authors declare that they have no competing interests.</p>
   </div>
</section>
<section><a name="sec7"></a><h3>Authors’ contributions</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">MH is the lead principal investigator on the project, leading its design and execution.
         She wrote the project proposal and manuscript. NK is responsible for the quality-of-life
         outcome of the study. DB is responsible for the pharmacoeconomic aspect of the study.
         AM is responsible for looking over the administrative issues in HMC, participates
         in the training of pharmacists and assists in following up the progress of the study.
         AK assists in preparing for the study pharmacists’ training, setting up the study
         sites, coordinating between members of the study team, and assessing the study outcomes
         in participants. NF is responsible for maintaining the quality checkup of data collection
         and participants’ recruitment done by the centers. She ensures the availability of
         the study materials and medications in all centers throughout the data collection
         period. ZM and MS will help in analyzing the study data. All authors read and approved
         the final manuscript.
      </p>
   </div>
</section>
<section><a name="ack"></a><h3>Acknowledgments</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">This publication was made possible by a grant from the Qatar National Research Fund
         under its National Priorities Research Program (NPRP). Its contents are solely the
         responsibility of the authors and do not necessarily represent the official views
         of the Qatar National Research Fund.
      </p>
      <p style="line-height:160%">We would like to thank Qatar Primary Health Care (PHC) and Qatar Petroleum (QP) administration
         and pharmacists for their support and participation in the project.
      </p>
   </div>
</section>
<section><a name="refs"></a><h3>References</h3>
   <div id="article-references" class="collapsible-content">
      <ol id="references">
         <li id="B1">
            <p><a name="B1"></a>Lande G. Nicotine addiction. [http://emedicine.medscape.com/article/287555-overview]
            </p>
         </li>
         <li id="B2">
            <p><a name="B2"></a>The World Health Organization. The top 10 causes of death Fact sheet [http://www.who.int/mediacentre/factsheets/fs310/en/index2.html]
            </p>
         </li>
         <li id="B3">
            <p><a name="B3"></a>The World Health Organization: Tobacco [http://www.who.int/mediacentre/factsheets/fs339/en/index.html]
            </p>
         </li>
         <li id="B4">
            <p><a name="B4"></a>The World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008 The
               MPOWER package [http://whqlibdoc.who.int/publications/2008/9789241596282_eng.pdf]
            </p>
         </li>
         <li id="B5">
            <p><a name="B5"></a>Center for Disease Control and Prevention: Smoking and Tobacco Use Cessation and Interventions
               [http://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm]
            </p>
         </li>
         <li id="B6">
            <p><a name="B6"></a> Roth MT,  Andrus MR,  Westman EC: <strong> Outcomes from an outpatient smoking cessation clinic. </strong><p><em>Pharmacotherapy</em> 2005,  <strong>25</strong>(2)<strong>:</strong>279-88.  <a target="_blank" href="/pubmed/15767242">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15767242">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B6" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B6','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B7">
            <p><a name="B7"></a>The World Health Organization: Tobacco Free Initiative [http://www.who.int/tobacco/research/economics/cessation/en/index.html]
            </p>
         </li>
         <li id="B8">
            <p><a name="B8"></a>Canadian Pharmacists Association. Joint Statement on Smoking Cessation- Tobacco the
               Role of Health Professionals in Smoking Cessation [http://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/PPSmokingCessation.pdf]
            </p>
         </li>
         <li id="B9">
            <p><a name="B9"></a> Hudmon KS,  Prokhorov AV,  Corelli RS: <strong> Tobacco cessation counseling: pharmacists’ opinions and practices. </strong><p><em>Patient Educ Couns</em> 2006,  <strong>61</strong><strong>:</strong>152-60.  <a target="_blank" href="/pubmed/16533683">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16533683">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B9" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B9','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B10">
            <p><a name="B10"></a> Aquilino ML,  Farris KB,  Zillich AJ,  Lowe JB: <strong> Smoking-cessation services in Iowa community pharmacies. </strong><p><em>Pharmacotherapy</em> 2003,  <strong>23</strong>(5)<strong>:</strong>666-73.  <a target="_blank" href="/pubmed/12741442">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=12741442">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B10" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B10','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B11">
            <p><a name="B11"></a>Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking
               cessation. Cochrane Database Syst Rev. 2004, Issue 1. Art. No.: CD003698. doi: 10.1002/14651858.CD003698.pub2.
            </p>
         </li>
         <li id="B12">
            <p><a name="B12"></a> Maguire TA,  McElnay JC,  Drummond A: <strong> A randomized controlled trial of a smoking cessation intervention based in community
                  pharmacies. </strong><p><em>Addiction</em> 2001,  <strong>96</strong>(2)<strong>:</strong>325-331.  <a target="_blank" href="/pubmed/11182878">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=11182878">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B12" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B12','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B13">
            <p><a name="B13"></a> Vial RJ,  Jones TE,  Ruffin RE,  Gilbert AL: <strong> Smoking cessation program using nicotine patches: linking hospital to the community. </strong><p><em>J Pharm Pract Res</em> 2002,  <strong>32</strong><strong>:</strong>57-62.  <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B13" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B13','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B14">
            <p><a name="B14"></a> Carroll P,  Rois R,  Sarson D,  Flynn J: <strong> A community pharmacy based smoking cessation program using transdermal nicotine replacement
                  therapy: actions and outcomes. </strong><p><em>Aust Pharmacist</em> 2000,  <strong>19</strong><strong>:</strong>51-5.  <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B14" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B14','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B15">
            <p><a name="B15"></a> Sinclair HK,  Bond CM,  Lennox AS,  Silcock J,  Winfield AJ,  Donnan PT: <strong> Training pharmacists and pharmacy assistants in the stage-of-change model of smoking
                  cessation: a randomized controlled trial in Scotland. </strong><p><em>Tob Control</em> 1998,  <strong>7</strong><strong>:</strong>253-61.  <a target="_blank" href="/pubmed/9825420">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=9825420">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B15" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B15','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B16">
            <p><a name="B16"></a> Zillich AJ,  Ryan M,  Adams A,  Yeager B,  Farris K: <strong> Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality
                  of life. </strong><p><em>Pharmacotherapy</em> 2002,  <strong>22</strong><strong>:</strong>759-65.  <a target="_blank" href="/pubmed/12066966">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=12066966">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B16" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B16','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B17">
            <p><a name="B17"></a> Dent LA,  Harris KJ,  Noonan CW: <strong> Randomized trial assessing the effectiveness of a pharmacist-delivered program for
                  smoking cessation. </strong><p><em>Ann Pharmacother</em> 2009,  <strong>43</strong>(2)<strong>:</strong>194-201.  <a target="_blank" href="/pubmed/19193572">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=19193572">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B17" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B17','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B18">
            <p><a name="B18"></a> Smith MD,  McGhan WF,  Lauger G: <strong> Pharmacist counseling and outcomes of smoking cessation. </strong><p><em>Am Pharm</em> 1995,  <strong>NS35</strong>(8)<strong>:</strong>20-9.  <a target="_blank" href="/pubmed/7677052">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=7677052">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B18" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B18','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B19">
            <p><a name="B19"></a> Kennedy DT,  Giles JT,  Chang ZG,  Small RE,  Edwards JH: <strong> Results of a smoking cessation clinic in community pharmacy practice. </strong><p><em>J Am Pharm Assoc (Wash)</em> 2002,  <strong>42</strong><strong>:</strong>51-6.   <a target="_blank" href="http://dx.doi.org/10.1331/108658002763538071">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B19" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B19','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B20">
            <p><a name="B20"></a> Dent LA,  Scott JG,  Lewis E: <strong> Pharmacist-managed tobacco cessation program in Veterans Health Administration community-based
                  outpatient clinic. </strong><p><em>J Am Pharm Assoc (Wash DC)</em> 2004,  <strong>44</strong><strong>:</strong>700-15.  <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B20" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B20','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B21">
            <p><a name="B21"></a> Crealey GE,  McElnay JC,  Maguire TA,  O’Neill C: <strong> Costs and effects associated with a community pharmacy-based smoking-cessation programme. </strong><p><em>Pharmacoeconomics</em> 1998,  <strong>14</strong>(3)<strong>:</strong>323-333.  <a target="_blank" href="/pubmed/10186470">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=10186470">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B21" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B21','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B22">
            <p><a name="B22"></a> McGhan WF,  Smith MD: <strong> Pharmacoeconomic analysis of smoking cessation interventions. </strong><p><em>Am J Health Syst Pharm</em> 1996,  <strong>53</strong>(1)<strong>:</strong>45-52.  <a target="_blank" href="/pubmed/8719289">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=8719289">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B22" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B22','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B23">
            <p><a name="B23"></a> Sinclair HK,  Silcock J,  Bond CM,  Lennox AS,  Winfield AJ: <strong> The cost-effectiveness of intensive pharmaceutical intervention in assisting people
                  to stop smoking. </strong><p><em>Int J Pharm Pract</em> 1999,  <strong>7</strong><strong>:</strong>107-12.   <a target="_blank" href="http://dx.doi.org/10.1111/j.2042-7174.1999.tb00957.x">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B23" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B23','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B24">
            <p><a name="B24"></a> Tran MT,  Holdford DA,  Kennedy DT,  Small RE: <strong> Modeling the cost-effectiveness of a smoking cessation program in a community pharmacy
                  practice. </strong><p><em>Pharmacotherapy</em> 2002,  <strong>22</strong>(2)<strong>:</strong>1623-31.  <a target="_blank" href="/pubmed/12495172">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=12495172">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B24" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B24','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B25">
            <p><a name="B25"></a>FIP Statement of Policy: the Role of the Pharmacist in Promoting a Tobacco Free Future.
               [https://www.fip.org/files/fip/news/tobacco-final2.pdf]
            </p>
         </li>
         <li id="B26">
            <p><a name="B26"></a>European Forum Pharmacists’ Charter on Action against Smoking [http://www.europharmforum.org/file/13612]
            </p>
         </li>
         <li id="B27">
            <p><a name="B27"></a>2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence:
               2008 update U.S. Public Health Service Clinical Practice Guideline executive summary.
               Respir Care. 2008;53(9):1217–22.
            </p>
         </li>
         <li id="B28">
            <p><a name="B28"></a> Hudmon KS,  Corelli RL: <strong> ASHP therapeutic position statement on the cessation of tobacco Use. </strong><p><em>Am J Health Syst Pharm</em> 2009,  <strong>66</strong><strong>:</strong>291-307.   <a target="_blank" href="http://dx.doi.org/10.2146/ajhp070303">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B28" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B28','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B29">
            <p><a name="B29"></a> Al-Kuwari MG: <strong> Tobacco control in Qatar. </strong><p><em>Middle East J Fam Med</em> 2008,  <strong>6</strong>(6)<strong>:</strong>11-3.  <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B29" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B29','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B30">
            <p><a name="B30"></a> Al-Mulla A,  Bener A: <strong> Cigarette smoking habits among Qatari population. </strong><p><em>Public Health Med</em> 2003,  <strong>4</strong>(3)<strong>:</strong>41-4.  <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B30" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B30','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B31">
            <p><a name="B31"></a>Global Youth Tobacco Surveillance, 2000-2007 [http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5701a1.htm]
            </p>
         </li>
         <li id="B32">
            <p><a name="B32"></a> Bener A,  Zirie M,  Kim EJ,  Buz R,  Zaza M,  Nufal , <em>et al</em>.: <strong> Measuring burden of diseases in a rapidly developing economy: state of Qatar. </strong><p><em>Glob J Health Sci</em> 2013,  <strong>5</strong>(2)<strong>:</strong>134-44.  <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B32" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B32','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B33">
            <p><a name="B33"></a> Ibrahim WH,  Rasul KI,  Khinji A,  Ahmed MS,  Bener A: <strong> Clinical and epidemiological characteristics of lung cancer cases in Qatar. </strong><p><em>East Mediterr Health J</em> 2010,  <strong>16</strong>(2)<strong>:</strong>166-70.  <a target="_blank" href="/pubmed/20799569">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20799569">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B33" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B33','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B34">
            <p><a name="B34"></a>Smoking—Addressing a National Epidemic [https://qatar-weill.cornell.edu/media/intoHealth/SmokingEpidemic.html]
            </p>
         </li>
         <li id="B35">
            <p><a name="B35"></a> El Hajj M,  Al-Nakeeb R,  Al-Qudah R: <strong> Smoking cessation counseling in Qatar: community Pharmacists’ attitudes, role perceptions,
                  and practices. </strong><p><em>Int J Clin Pharm</em> 2012,  <strong>34</strong>(4)<strong>:</strong>667-76. 
               <p> doi: 
                  
                  10.1007/s11096-012-9663-x
                  
                  
               </p> <a target="_blank" href="/pubmed/22733168">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22733168">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B35" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B35','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B36">
            <p><a name="B36"></a>Smoking cessation clinic [http://stopsmoking.hamad.qa/ar/clinic/clinic.aspx]
            </p>
         </li>
         <li id="B37">
            <p><a name="B37"></a>Sackey JA. Smoking cessation counseling strategies in primary care. [http://www.uptodate.com/contents/smoking-cessation-counseling-strategies-in-primary-care?source=search_result&amp;search=Smoking+cessation+counseling+strategies+in+primary+care&amp;selectedTitle=1~150]
            </p>
         </li>
         <li id="B38">
            <p><a name="B38"></a> Kennedy DT,  Small RE: <strong> Development and implementation of a smoking cessation clinic in community pharmacy
                  practice. </strong><p><em>J Am Pharm Assoc</em> 2002,  <strong>42</strong>(1)<strong>:</strong>83-92.   <a target="_blank" href="http://dx.doi.org/10.1331/108658002763538116">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B38" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B38','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B39">
            <p><a name="B39"></a> Heatherton TF,  Kozlowski LT,  Frecker RC,  Fagerström KO: <strong> The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance
                  questionnaire. </strong><p><em>Br J Addict</em> 1991,  <strong>86</strong>(9)<strong>:</strong>1119-27.  <a target="_blank" href="/pubmed/1932883">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=1932883">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B39" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B39','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B40">
            <p><a name="B40"></a> Al Mohamed HI,  Amin TT: <strong> Pattern and prevalence of smoking among students at King Faisal University, Al Hassa,
                  Saudi Arabia. </strong><p><em>EMHJ</em> 2010,  <strong>16</strong>(1)<strong>:</strong>56-64.  <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B40" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B40','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B41">
            <p><a name="B41"></a> Asfar MD,  Vander MW,  Maziak W,  Hammal F,  Eissenberg T,  Ward KD: <strong> Outcomes and adherence in Syria’s first smoking cessation trial. </strong><p><em>Am J Health Behav</em> 2008,  <strong>32</strong>(2)<strong>:</strong>146-56.  <a target="_blank" href="/pubmed/18052855">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18052855">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B41" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B41','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B42">
            <p><a name="B42"></a> Olufade AO,  Shaw JW,  Foster SA,  Leischow SJ,  Hays RD,  Coons SJ: <strong> Development of the smoking cessation quality of life questionnaire. </strong><p><em>Clin Ther</em> 1999,  <strong>21</strong>(12)<strong>:</strong>2113-30.  <a target="_blank" href="/pubmed/10645757">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=10645757">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B42" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B42','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B43">
            <p><a name="B43"></a>Smoking Cessation Quality of Life (SCQoL) Questionnaire [http://qol.thoracic.org/sections/instruments/pt/pages/scqol.html]
            </p>
         </li>
         <li id="B44">
            <p><a name="B44"></a> Hudmon KS,  Berger BA: <strong> Pharmacy applications of the transtheoretical model in smoking cessation. </strong><p><em>Am J Health Syst Pharm</em> 1995,  <strong>52</strong><strong>:</strong>282-7.  <a target="_blank" href="/pubmed/7749955">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=7749955">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B44" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B44','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B45">
            <p><a name="B45"></a>DRUGDEX® Evaluations: Nicotine [http://www.micromedexsolutions.com/home/dispatch]
            </p>
         </li>
         <li id="B46">
            <p><a name="B46"></a>DRUGDEX® Evaluations: Nicotine polacrilex [http://www.micromedexsolutions.com/home/dispatch]
            </p>
         </li>
         <li id="B47">
            <p><a name="B47"></a> Jatlow P,  Toll BA,  Leary V,  Krishnan-Sarin S,  O’Malley SS: <strong> Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette
                  abstinence. </strong><p><em>Drug Alcohol Depend</em> 2008,  <strong>98</strong>(3)<strong>:</strong>203-9.  <a target="_blank" href="/pubmed/18650033">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18650033">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B47" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B47','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B48">
            <p><a name="B48"></a> Borelli B,  Hogan J,  Bock B,  Pinto B,  Roberts M,  Marcus B: <strong> Predictors of quitting and dropout among women in a clinic-based smoking cessation
                  program. </strong><p><em>Psychol Addict Behav</em> 2002,  <strong>16</strong>(1)<strong>:</strong>22-7.   <a target="_blank" href="http://dx.doi.org/10.1037/0893-164X.16.1.22">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B48" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B48','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B49">
            <p><a name="B49"></a>Though the smoke: Tobacco use in the Middle East [http://www.ispu.org/Getpolicy/34/1846/Publications.aspx]
            </p>
         </li>
         <li id="B50">
            <p><a name="B50"></a> Kheir N,  Zaidan M,  Younes H,  El Hajj M,  Wilbur K,  Jewesson PJ: <strong> Pharmacy education and practice in 13 Middle Eastern countries. </strong><p><em>Am J Pharm Educ</em> 2008,  <strong>72</strong>(6)<strong>:</strong>1-13.   <a target="_blank" href="http://dx.doi.org/10.5688/aj7206133">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0570-z&amp;bibl=B50" onclick="popup('/sfx_links?ui=s13063-015-0570-z&amp;bibl=B50','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
      </ol>
   </div>
</section>
    <br class="clearall">
<div class="article-alert-signup-div">

<a class="close png_bg" id="closeHelpBox" >close</a>	
<div class="article-alert-signup rounded" > 
<span class="blurb left">Sign up to receive new article alerts from <em>Trials</em></span>

	
				<button name="articleAlertPreference.status" type="button" class="w74 right" onClick="window.location='/my/preferences'">Sign up</button>
	
</div>
</div></div>
    </div></div>
</div>


		</div>
</div>

    <hr class="hide" />
	
    

						
   
  
      
  
                  
  
                  
  
            
  
            
            


<div id="footer">

						
			<span class="views"><a id="mobile-view" href="?fmt_view=mobile">Mobile view</a> | <strong>Desktop view</strong></span>
			
	<div class="content">
    <div class="rounded ">
<div class="wrap-inner ">
        	
    <ul class="desktop">
                                                    
				        <li class="noborder"><a href="http://www.biomedcentral.com/about/tandc">Terms and Conditions</a></li>
<li><a href="http://www.biomedcentral.com/about/privacy">Privacy statement</a></li>
<li><a href="http://www.biomedcentral.com/presscenter">Press</a></li>
	<li><a href="http://www.biomedcentral.com/advertisers">Information for advertisers</a></li>
<li><a href="http://www.biomedcentral.com/about/bmcjobs">Jobs at BMC</a></li>
<li><a href="/support">Support</a></li>
<li><a href="/about/contact">Contact us</a></li>


    
    	    </ul>
    <p id="copyright">&copy; 2015 
	BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business&nbsp;Media.</p>
        </div>
</div>

	</div>

</div>
<div class="springer">
    <a href="http://www.springer.com/" target="blank"><img style="float:right; margin:0;" src="
    //www.biomedcentral.com/images/Springer_Branding_footer_logo.png" /></a>
</div>


<script>window.bmcIsMobile = "classic";</script>					    

<script>
// getElementsByClassName Polyfill
var getElementsByClassName=function(e,t,n){if(document.getElementsByClassName){getElementsByClassName=function(e,t,n){n=n||document;var r=n.getElementsByClassName(e),i=t?new RegExp("\\b"+t+"\\b","i"):null,s=[],o;for(var u=0,a=r.length;u<a;u+=1){o=r[u];if(!i||i.test(o.nodeName)){s.push(o)}}return s}}else if(document.evaluate){getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i="",s="http://www.w3.org/1999/xhtml",o=document.documentElement.namespaceURI===s?s:null,u=[],a,f;for(var l=0,c=r.length;l<c;l+=1){i+="[contains(concat(' ', @class, ' '), ' "+r[l]+" ')]"}try{a=document.evaluate(".//"+t+i,n,o,0,null)}catch(h){a=document.evaluate(".//"+t+i,n,null,0,null)}while(f=a.iterateNext()){u.push(f)}return u}}else{getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i=[],s=t==="*"&&n.all?n.all:n.getElementsByTagName(t),o,u=[],a;for(var f=0,l=r.length;f<l;f+=1){i.push(new RegExp("(^|\\s)"+r[f]+"(\\s|$)"))}for(var c=0,h=s.length;c<h;c+=1){o=s[c];a=false;for(var p=0,d=i.length;p<d;p+=1){a=i[p].test(o.className);if(!a){break}}if(a){u.push(o)}}return u}}return getElementsByClassName(e,t,n)}
</script>

						



<script type="text/javascript">
if (typeof jQuery == 'undefined') { document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.min.js' type='text/javascript'%3E%3C/script%3E")); }


document.documentElement.id = "js";

var site = {
			abbreviation: "",
	        type: "BMC_NICHE",
        portalId: "9001",
                section: "browse",
                page: "fulltext",
    		
									homePortal: "biomedcentral.com",
		
			siteShowAds: "true",
				showAds: "true",
				url: "trialsjournal.com",
			portal: false,
	        adpage_url: "trialsjournal.com/article/10.1186/s13063/015/0570/z",
        id: "10096",
	name: "Trials",
	plugins: {
		scrollable: (getElementsByClassName("scrollable").length > 0),
				flowplayer: ((document.getElementById("flowplayer") != null) || (getElementsByClassName("myPlayer").length > 0) || (document.getElementById("videoarticle") != null) || (getElementsByClassName("flowplayer").length > 0) || (document.getElementById("audio") != null) || (document.getElementById("elifeplayer") != null)),
		lightbox: ((document.getElementById("image-highlight") != null) || (getElementsByClassName("lightbox").length > 0)),
		thickbox: (getElementsByClassName("thickbox").length > 0),
		altmetric: ((document.getElementById("altmetric") != null) || (getElementsByClassName("altmetric").length > 0))
	}
	
};



if(typeof quoteSearchUri == "undefined") { quoteSearchUri=null; }
</script>



        <script type="text/javascript" src="http://www.bmcimg.com/javascript/journals/behaviours-0.js"></script>






		<script>
	if (site.plugins.scrollable == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.scrollable-1.0.1.min.js' %3E%3C/script%3E")); 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.tools.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.flowplayer == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/flowplayer-3.2.6.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.lightbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/browse_imagehighlight.js'%3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.colorbox.js' %3E%3C/script%3E"));
	}

	if (site.plugins.thickbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-compressed.js' %3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-flashhidden-patch.js' %3E%3C/script%3E"));
	}
	</script>





            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.fancybox-1.3.1.pack-0.js"></script>
            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.debug-0.js"></script>
                      <script type="text/javascript" src="http://www.bmcimg.com/javascript/email_preferences/email_preferences-0.js"></script>
                <script type="text/javascript" src="http://www.bmcimg.com/javascript/articles/articles-0.js"></script>
		<div id="fb-root"></div>











        <script type="text/javascript" src="/javascript/plugins/jquery.tagcloud.min-0.js"></script>




<!--[if lte IE 6]>
            <script type="text/javascript" src="/javascript/plugins/DD_belatedPNG_0.0.8a-0.js"></script>
    <script type="text/javascript">
        DD_belatedPNG.fix('.png_bg, ul.primary-nav li a, ul.primary-nav li a span, ul.secondary-nav li a, ul.secondary-nav li a span, ul li i, .plus-button, .facebook, .twitter, .fancy-bg, #fancybox-close');
    </script>
	                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/hacks/ie6-0.css"/>
    <![endif]-->

<!-- Claudia Whitcombe wanted this comment here -->

       <div class="hide">
      <dl class="google-ad" id="x96banner">
        <dt style="display: block;" class="hide">
          <a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
       </dt>
        <dd>
          <!-- OAS AD 'x96' begin -->
          <script type="text/javascript">
            OAS_AD('x96');
          </script>
        </dd>
      </dl>
    </div>  
    
</body>
</html>

